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1.  Summary 
Human cytomegalovirus (HCMV) is a large encapsulated virus belonging to the 
herpesvirus family. Following asymptomatic infection, life-long latency is established 
in the host and 50-80% of the general population is seropositive. This virus can 
cause life-threatening infections in immunocompromised patients after 
transplantation, in neonates or in people infected with human immunodeficiency 
virus. Primary infection or reactivation of HCMV are major causes of morbidity and 
mortality. 
Suppressor of cytokine signaling (SOCS) proteins are very potent negative 
regulators of the janus kinase/signal transducer and activator of transcription 
(JAK/STAT) pathways. JAK/STAT are key players for numerous immunological 
relevant pathways including the interferon (IFN) pathway, one of the most powerful 
cellular antiviral defense mechanism. A number of viruses have been described to 
exploit SOCS signaling to attenuate the immune response of the infected cell and 
facilitate replication. Two herpesviruses, herpes simplex virus 1 and Epstein Barr 
virus, upregulate SOCS1 and in particular SOCS3 to their advantage. Based on this 
findings, we hypothesized that HCMV may take advantage of SOCS1 or/and SOCS3 
as an evasion mechanism. The data presented in this thesis describe the process of 
investigation that led to the final results demonstrating that efficient replication of 
HCMV in primary endothelial cells is depended on SOCS3 protein. First experiments 
were carried out in porcine endothelial cells. The goal was to evaluate possible 
modulation of SOCS proteins by HCMV infection in a cross-species model of 
xenotransplantation. After observing a modulation of SOCS1 mRNA in porcine 
primary endothelial cells we focused on the human setting, using our established 
model of HCMV infection in primary endothelial cells. 
Time course analysis of HCMV infected human endothelial cells revealed an 
increase of SOCS3 protein in infected cells. Silencing of SOCS3 resulted in a 
partially inhibited production of viral antigens. Consistently, the number of infectious 
particles produced in SOCS3 silenced (siSOCS3) cultures was significantly lower as 
compared to SOCS1 silenced (siSOCS1) or control transfected cultures (siCNTR). 
Impairment of the viral replication process due to SOCS3 silencing occurred after 
entry since the number of infected cells was identical in all three siSOCS1, siSOCS3 
or siCNTR conditions. STAT1 phosphorylation, a key transcription factor for type I 
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and II IFN, was increased in siSOCS3 and siSOCS1 infected cells when compared to 
siCNTR-treated cells. In contrast, phosphorylation of STAT2, key factor of type I IFN, 
was only increased in siSOCS3 infected-cultures. Analysis of the ability of the virus 
to control IFNβ-inducible gene expression showed that the HCMV-infected fraction of 
siSOCS3 culture had a higher percentage of cells expressing IFNβ-induced major 
histocompatibility complex class I molecules as compared with siSOCS1 or siCNTR 
cultures.  
In conclusion this study demonstrates for the first time that SOCS3 plays a critical 
role for efficient HCMV replication in primary endothelial cells and provides evidence 
for an involvement of SOCS3 in HCMV-mediated control of the type I IFN pathway. 
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2.  Zusammenfassung 
Humane Zytomegaloviren (HZMV) gehören zur Familie der Herpesviren. Die 
Infektion ist in der Regel asymptomatisch, und führt zur Latenz, d.h. lebenslangen 
Persistenz im Wirt. 50%-80% der allgemeinen Bevölkerung sind seropositiv für 
HZMV. Dieses Virus ist besonders relevant für Menschen mit einer angeborenen 
oder erworbenen Immunschwäche, wie transplantierte Patienten, Neugeborene und 
Personen, die mit dem humanen Immunodefizienz Virus infiziert sind. Sowohl die 
Erstinfektion als auch die Reaktivierung von HZMV resultiert in einer erheblichen 
Morbidität und Mortalität. 
Suppressor of Cytokine Signaling (SOCS)-Proteine sind sehr potente negative 
Regulatoren des Janus-Kinase/Signal-Wandler und Aktivatoren der Transkription 
(JAK/STAT) Kaskaden. JAK/STAT spielen eine wichtige Rolle in vielen 
immunologisch relevanten Signalwegen, unter anderem der Interferon (IFN)-
Kaskade, die eine der potentesten zellulären antiviralen Abwehrmechanismen 
darstellt. Einige Viren sind beschrieben worden, die SOCS-Proteine ausnützen, um 
die Immunantwort der infizierten Zellen zu dämpfen und damit ihrer Replikation zu 
erleichtern. Bei zwei Herpesviren, Herpes simplex Virus 1 und Epstein Barr Virus 
konnte gezeigt werden, dass diese SOCS1 und SOCS3 zu ihrem Vorteil regulieren. 
Auf dieser Grundlage haben wir die Hypothese formuliert, dass HZMV SOCS1 
oder/und SOCS3 für die eigene Replikation moduliert. Die hier präsentierten 
Resultate zeigen, dass eine effiziente Replikation von HZMV in primären 
Endothelzellen massgebend vom SOCS3 Protein abhängt. 
Die ersten Experimente wurden in porzinen Endothelzellen durchgeführt. Diese 
Erkenntnisse sollten helfen, dass Risiko einer Spezies-übergreifenden Infektion 
besser abzuschätzen. Dieses Szenario ist bis jetzt nur in wenigen klinischen Studien 
Realität, bei denen Diabetes Patienten porzine Inselzellen verabreicht werden. 
Die Modulierbarkeit der SOCS Gene in porzinen Endothelzellen motivierte uns, die 
Situation in einem menschlichen Modell genauer zu untersuchen. Dabei benützten 
wir das in unserem Labor entwickelte Modell der HZMV Infektion menschlicher 
Endothelzellen. 
HZMV infizierte menschliche Endothelzellen zeigten eine Zunahme von SOCS3 
Protein. Das gezielte Ausschalten des SOCS3 Genes (silencing, siSOCS3) führte zu 
einer teilweise gehemmten Produktion von viralen Antigenen. Als Folge war die 
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Anzahl der infektiösen Partikel in siSOCS3 Kulturen deutlich niedriger verglichen mit 
siSOCS1 oder kontroll-transfizierten Kulturen (siCNTR).  
Die deutlich eingeschränkte Replikation in siSOCS3 Kulturen trat erst nach Eintritt 
des Virus in die Zelle auf, da die Zahl der infizierten Zellen in allen drei 
Versuchsanordnungen (siSOCS1, siSOCS3 oder siCNTR) identisch war. STAT1 
Phosphorylierung, ein wichtiger Transkriptionsfaktor für Typ I und II IFN war in 
siSOCS3 und siSOCS1 infizierten Zellen erhöht im Vergleich mit den siCNTR-
behandelten Zellen. Im Gegensatz dazu wurde die Phosphorylierung von STAT2, 
Schlüsselfaktor des Typ I IFN, nur in siSOCS3 infizierten Kulturen beobachtet.  
Die Analyse der durch das Virus kontrollierten IFNß-induzierbaren Genexpression 
zeigte, dass die HCMV-infizierten siSOCS3 Kulturen einen höheren Prozentsatz von 
Zellen zeigte, die IFNß-induzierte Haupthistokompatibilitätskomplex Klasse I 
Moleküle exprimieren als in siSOCS1 oder siCNTR Kulturen. Diese Studie zeigt zum 
ersten Mal, dass SOCS3 für eine effiziente Replikation vom HZMV in primären 
Endothelzellen eine entscheidende Rolle spielt. HZMV hemmt dabei durch SOCS3 
die Typ I IFN Antwort und begünstigt dadurch die eigene Replikation. 
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3.  Introduction 
 
3.1 Human cytomegalovirus 
 
3.1.1 Epidemiology and clinical relevance 
Human cytomegalovirus (HCMV) primary infection is mainly asymptomatic. Life-long 
latency is established after infection, resulting in a seropositivity of 50-80% of the 
general population. This is of relevance for immunocompromised hosts like 
neonates, patients infected with human immunodeficiency virus or recipients after 
solid and stem cell transplantation. HCMV primary infection and reactivation is a 
major cause of mortality [1] in this vulnerable population. Despite a worldwide effort 
no vaccination has yet reached the clinical routine. In the 1970s first treatment 
options with antiviral drugs showed a decrease in mortality after HCMV infection [2]. 
Currently marketed anti-CMV drugs are ganciclovir, its oral prodrug valganciclovir, 
foscarnet, cidofovir and fomivirsen. Except for fomivirsen, which is an antisense RNA 
targeting expression of immediate early gene 72 and is only applied intraocularly, the 
other drugs target the viral DNA polymerase. Prolonged treatment with these drugs 
has led to emerging resistant viral strains [3,4]. Moreover, toxicity limits duration and 
applicability. Alternative antiviral compounds with new mechanisms of action, such 
as artesunate, leflunomid, letermovir and maribavir, are now being investigated in 
clinical studies. An advantage of some of the new substances is a favorable toxicity 
profile, which might lead to new prophylactic and treatment strategies [5]. HCMV 
remains a highly investigated pathogen and every step elucidating its biology may 
potentially lead to the development of new treatment options and improve outcome 
after infection. 
 
3.1.2 Structure and replication cycle 
HCMV is a big enveloped virus, which belongs to the β-herpesvirus family, and is 
known as herpes virus type 5. The virion has an icosahedral structure and contains a 
230Kb double stranded DNA genome [1]. The envelope is made out of 6 viral 
glycoproteins (gB, gH, gL, gM, gN and gO) that are responsible for virus docking and 
cellular entry. Infection of HCMV occurs by an interaction between the cellular 
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heparan sulfate proteoglycans and the viral proteins gB and gM complex (Figure 
3.1). Epidermal growth factor (EGF) receptor is believed to be involved in the entry 
process, however the data are controversial [6]. Platelet-derived growth factor-α 
receptor has been shown to be important for HCMV infection of fibroblast, epithelial 
and endothelial cells [7]. After entry into the target cells the viral genome rapidly 
reaches the nucleus.  
  
Figure 3.1: Model of HCMV entry into the host cell 
The diagram shows HCMV entry into human cells. Initial attachment occurs by binding of viral 
envelope gB to heparan sulfate proteoglycans. This low-affinity attachment is followed by high 
affinity attachment of gB to an unidentified receptor. Finally, in a step which depends on a 
viral glycoprotein complex of gH, gL, and gO, the lipid bilayers fuse and the virion is released 
into the cytoplasm (Adapted from [8]). 
 
HCMV genome encodes for more than 200 proteins. Expression of these proteins is 
divided in three overlapping phases: immediate early (IE), early (E) and late (L) 
(Figure 3.2). IE antigens expression occurs very rapidly after entry, within the first 2-4 
hours. These proteins are responsible for activation of later viral gene transcription 
and regulate expression of numerous cellular genes affecting the immune response 
of the host cell and clearance mechanisms [9,10]. E antigens expression starts within 
the first 24 hours after infection and depends on IE expression. These proteins are 
responsible for viral genome replication and are involved in immune evasion as well 
[10]. Expression of L proteins takes place at the final stage of the infection, beginning 
48 hours post infection (p.i.) and is depending on viral genome replication. These 
proteins are mainly structural proteins required for virus assembly and budding [10-
12]. Finally mature viral particles are released starting 72 hours p.i. by an exocytic-
like pathway [12]. 
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Figure 3.2: Steps of viral antigens production during HCMV replication 
Detection of viral antigen in infected cells starts 2-4 hours p.i. with IE antigens, followed about 
24 hours p.i. by E antigens and 48-72 hours p.i. by L antigens. [13], immunofluorescence 
images from our laboratory show IE (left), E (middle) and L (right) staining. 
 
3.1.3 Role in allo- and xenotransplantation 
Patients undergoing solid organ transplantation have to be immunosuppressed to 
reduce the possibility of rejection of the graft. In this context HCMV infection poses a 
danger as reactivation or primary infection by transmission of HCMV from a 
seropositive donor to a seronegative recipient may result in disease. HCMV infection 
has been correlated with rejection for all type of solid organ transplants [14-21]. It can 
affect the donor in a direct or indirect manner. The direct effect (called CMV disease) 
is characterized by a high-rate viral replication leading to pneumonitis, 
gastrointestinal disease, hepatitis, retinitis and encephalitis [22]. The indirect effects 
of HCMV are characterized by a low rate of replication over a long period of time. 
This has been associated with a higher risk of graft rejection and opportunistic 
infections and may lead to the development of diabetes and arteriosclerosis [22,23].  
In view of the currently performed clinical trials using porcine islets for diabetic 
patients as well as large animal studies performed with the goal of implanting pig 
organs into human recipients (xenotransplantation), investigations in the pig to 
baboon model has revealed both direct and indirect effect of pig and baboon CMV 
reactivation, resulting in death of some of the baboons [24]. Recently HCMV infection 
of porcine endothelial cells (pEC) was demonstrated [25] and further characterized 
[26,27]. These studies not only demonstrated that HCMV can enter and actively 
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replicate in pEC leading to production of infectious particles but did show an impact 
on the phenotype of infected cells. In view of the potential pig to human 
transplantation of solid organs, it is important to investigate HCMV infection of pEC to 
evaluate the impact and possible effects. 
 
3.1.4 The role of the endothelium  
HCMV can productively infect a number of different cells including but not limited to 
epithelial, endothelial, smooth muscle and mesenchymal cells, as well as monocyte-
derived macrophages, fibroblasts, granulocytes and hepatocytes [28]. In the context 
of transplantation the endothelium plays a crucial role. Being at the interface between 
blood and tissue the endothelium is the first barrier and contact surface between 
donor graft and recipient blood. It has been shown to be a natural site of infection for 
HCMV in vivo following primary infection [29-33] and it is believed to act as a viral 
reservoir [34] involved in viral spread and persistence. Virus-mediated changes in the 
phenotype of infected endothelial cells (EC) may contribute to the dissemination of 
the virus into organs and has been associated with viral pathogenicity. [35].  
Given the combined importance, the EC were chosen for our model. 
 
3.1.5 Multifaceted escape mechanisms form host immune defense 
Following HCMV infection both innate and adaptive immune responses are elicited. 
The innate response starts within minutes after infection of the cell and induces the 
expression of inflammatory genes, most of them belonging to the interferon (IFN) 
family [6,10]. HCMV has developed a number of strategies to elude innate responses 
which vary depending on the virus strain and the cell type studied [9]. 
HCMV has been shown to interfere with type I and II IFN (Figure 3.3) activation at 
different levels. Again, the observed alterations are highly dependent on the model 
investigated [9]. Characterization of fibroblast infection with the HCMV laboratory 
strain Towne, which is commonly used in many models, has revealed inhibition of 
type II IFN at different levels after infection, starting with the inhibition of class II 
transactivator expression, about 6h p.i. [36], followed by the inhibition of signal 
transducer and activator of transcription 1 (STAT1) phosphorylation by src homology 
region 2 domain-containing phosphatase, about 16h p.i. [37], and finally disruption of 
janus kinase 1 (JAK1) 72h p.i. [38]. Downregulation of IFNγ-induced major 
histocompatibility complex class II (MHC-II) expression in HCMV infected cells has 
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been shown [36,38-41]. JAK1 disruption by HCMV has an influence on type I IFN 
activation since it is a shared component of both the type I and II IFN pathway 
(Figure 3.3). 
 
Figure 3.3: Type I and II IFN pathways 
A simplified summary of type I and II IFN pathway activation is shown. IFN type I (most 
important members are IFNα and IFNβ) and type II (only member is IFNγ) pathways start 
after cytokine docking to the receptor. After engaging JAK1 and TYK2 for type I IFN and 
JAK1 and JAK2 for type II IFN, the cascade leads to STAT1/STAT2 or STAT1/STAT1 
phosphodimers generation, respectively. Once the dimers translocate to the nucleus (with the 
help of cofactors like IFN regulatory factor-9 (IRF9) they finally activate the transcription of the 
target genes (Adapted from the Swiss Institute of Bioinformatic 
http://viralzone.expasy.org/all_by_protein/784.html) 
 
In addition to JAK1, p48, another key factor of the type I IFN pathway, has been 
found to be destroyed in HCMV infected cells [42]. HCMV can directly affect the type 
I IFN pathway, inhibiting IFN type I stimulated MHC class I, IFN regulatory-1, 
myxovirus resistance A (Mx) and 2,5-oligoadenylate synthetase genes expression in 
fibroblast and human umbilical vein endothelial cells (HUVEC) [9,42]. These results 
are in conflict with others showing an upregulation of these genes in HCMV infected 
fibroblasts [43-49]. 
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It was recently shown that in HCMV infected fibroblast a decrease in STAT2 
phosphorylation is followed by a reduction in the total amount of this protein. This 
phenomenon was found to be strain depended and not observed for Towne virus 
[50]. An active involvement of E viral proteins in the control of STAT2 has been 
suggested [50]. More recently, in fibroblast, a physical interaction of STAT2 and the 
viral protein IE72 has been observed which was connected to the ability of the virus 
to control the STAT2 activation [51]. 
The innate response rapidly limits viral replication and induces the adaptive arm. 
Antibodies against HCMV persist lifelong after infection [1]. Nevertheless, HCMV is 
capable of establishing life-long latency [52]. Escape from the adaptive response 
depends on the ability of the virus to induce expression of genes that interfere with 
the mechanisms of cellular mediated clearance [1,53,54]. Expression of unique short 
proteins (e.g. US2, US3, US6 and US11) lead to human leukocyte antigen (HLA) 
class I and II degradation, inhibition of transcription or internalization and as 
consequence T cell-mediated recognition of infected cells is inhibited [55]. Natural 
killer (NK) cell response is inhibited by the viral protein gpUL40, which induces HLA-
E molecule expression in infected cells. HLA-E binds to NK cells receptor inhibiting 
the cytotoxic effect of this cells thus protecting the infected cells from NK cell-
mediated clearance [56,57]. The viral proteins gpUL16 and gpUL141 interfere with 
NK cells by binding the NK activator receptor natural killer group 2 member D 
(NKG2D) and DNAX accessory molecule-1 (DNAM-1), leading to inhibition of the NK 
killing process [58-61]. HCMV can efficiently interfere with the apoptotic process 
promoting the survival of infected cells [54,62]. Inhibition of apoptosis has been 
shown to be one of the main barriers for cross species infection (HCMV to pEC). 
HCMV is very inefficient in controlling this pathway probably because of differences, 
between human and pig, in the structure of cellular proteins involved in this process 
[26,63]. 
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3.2 Suppressor of cytokine signaling proteins 
 
3.2.1 The origins 
In 1995 a protein called CIS (cytokine-inducible SH2) was identified by differential 
expression in the presence of interleukin 3 (IL-3) and erythropoietin (EPO) [64]. Two 
years later three independent groups discovered a second member of the same 
family, called suppressor of cytokine signaling 1 (SOCS1) protein via three different 
approaches: based on the homology with STAT3 central domain [65], based on a 
yeast-two-hybrid screen reveling interaction with JAK2 tyrosine kinase JH1 domain 
[66] and as inhibitor of IL-6 induced macrophage cell line differentiation [67]. These 
three first publications revealed the common role for SOCS1 as an inhibitor of 
JAK/STAT related signals [65-67].  
Eight members of the SOCS protein family have been identified so far: CIS, SOCS1, 
SOCS2, SOCS3, SOCS4, SOCS5, SOCS6, SOCS7 [67-69]. Their main role is to 
modulate the response of cells to cytokines by attenuating the activation of target 
pathways, usually JAK/STAT family [70]. They are particularly important to restore 
the homeostasis after activation by cytokines (e.g. IFNγ, IL-6) [71] acting as inhibitors 
of the JAK/STAT pathway in a negative feedback loop manner leading to the 
attenuation of the transduction signals [65,71,72].  
 
 
 
Figure 3.4: Suppressor of cytokine signaling 
proteins structure 
SOCS proteins all share the same basic structure 
composed by an N-terminal domain which is 
variable in length and sequence, an SH2 domain 
and a C-terminal domain called SOCS box. 
SOCS1 and SOCS3 in addition show a kinase 
inhibitor region (KIR) (adapted from [73]). 
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3.2.2 Structure and function 
SOCS proteins are characterized by their particular composition. They all share the 
same structure with an SH2 and a C-terminal SOCS box motive (Figure 3.4). Indeed, 
after the identification of CIS and SOCS1, the other member of this family were 
identified through database searches for proteins that contained a SH2 and SOCS 
box [68,69]. 
 
Figure 3.5: SOCS and JAK/STAT pathway 
Once a cytokine binds to its receptor activation of the JAK/STAT pathways occurs. This leads 
to the transcription of target genes, including SOCS. SOCS protein act in a negative feedback 
manner attenuating the transduction of the pathway by (1) competing with STAT for the 
phosphotyrosine residue on the receptor, (2) inhibiting JAK activity (by KIR, only for SOCS1 
and SOCS3) or binding the target proteins with the SH2 domains allowing polyubiquitination 
and consequent destruction in the proteasome (adapted from [74]).  
 
The function is tightly related to the structure: the SOCS proteins attenuate the 
transduction and activation of JAK/STAT related pathways [75]. The SH2 domain 
binds to a phosphorylated tyrosine residue of the target protein, usually a kinase. The 
SOCS box is a binding site for the ubiquitin machinery [76]. Once a target protein is 
bound to the SH2 domain (e.g. JAK) the ubiquitin machinery allows 
polyubiquitination, targeting the SH2 recognized protein for proteasomal degradation 
(Figure 3.5). SOCS1 and SOCS3 have an additional particular sequence, called 
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kinase inhibitor region (KIR), which is located close to the N-terminal part of the SH2 
domain. KIR can directly inhibit the kinase activity of target proteins. Therefore 
SOCS1 and SOCS3 do not only inhibit the transduction of the signal through SOCS 
box mediated polyubiquitination but can directly interact with the kinase activity of the 
target protein [75]. 
 
3.2.3 SOCS features 
Out of the 8 proteins belonging to this family SOCS1 and SOCS3 are the most 
investigated members followed by CIS and SOCS2. SOCS4, SOCS5, SOCS6 and 
SOCS7 are in contrast not very well characterized so far and seem to be less 
involved in control of cytokines signaling as compared to SOCS1 and SOCS3. 
Investigations of SOCS family proteins have revealed that SOCS proteins with short 
N-terminal region (CIS, SOCS1, SOCS2 and SOCS3) are associated with disease 
states, whereas long terminal region does not seem to involved in this context [77-
79]. Most research has focused on short N-terminal region SOCS, mainly SOCS1 
and SOCS3. They play a key role in a number of biological processes and have been 
described to be relevant in a broad range of fields, like cancer biology [80-82] , 
immunology [83,84], inflammation [85,86] and virology [74]. A table (Table 3.1) 
summarizes the stimuli that induce the SOCS expression and the pathway affected. 
The following chapter highlights the main findings of the first 15 years after their 
discovery. 
 
3.2.3.1 SOCS1 
SOCS1 is mainly induced by type I and II IFN but not exclusively (Table 3.1). Studies 
in mice have shown that at birth SOCS1 deficient mice (SOCS1-/-) were found to be 
healthy but smaller than wild-type mice. Thereafter these knock out mice show 
activation of peripheral T-cells, lymphopenia, macrophage infiltration in many tissues, 
fat degeneration and necrosis of the liver which results in death within three weeks 
[87,88]. These effects are thought to be due to a dysregulation of the immune 
system. In these mice STAT1 was found to be constitutively activated; in mice 
lacking type II IFN receptor and SOCS1, 3 weeks after birth, the lethal phenotype 
was not observed. These findings suggest that SOCS1 is a crucial negative regulator 
of type II IFN pathway [89-91]. However, despite an initial protection, type II IFN 
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receptor and SOCS1 mutated mice still died after 6 weeks of life, developing 
inflammation and polycystic kidneys [92]. 
 
Table 3.1: Factor involved in SOCS expression and regulation (Adapted from [93]) 
Abbreviations: IGF-1, insulin-like growth factor-1; LIF, leukemia inhibitory factor; M-CSF, 
macrophage-colony stimulating factor; G-CSF, granulocyte colony stimulation factor; 
CNTF, ciliary neuronotrophic factor; GH, growth hormone; PAMPs, pathogen-associated 
molecular patterns; TPO thrombopoietin; TSLP, thymic stromal lymphopoietin; TSH, thyroid 
stimulating hormone; GM-CSF granulocyte-macrophage colony-stimulating factor; 
other explained in the text and in the abbreviation list. 
 
 
Interestingly SOCS1-/- mutant mice restricted to the hematopoietic compartment 
resulted in neonatal death. Constitutive activation of STAT1 and high expression of 
type II inducible genes were detected, suggesting that the hematopoietic stem cells 
plays a crucial role in the development of the lethal phenotype [94]. 
SOCS1 mRNA is transcribed by STAT1, STAT3 and STAT6 [65,95] and needs 
methylation of the CpG island within the promoter. The translation efficiency of 
SOCS1 mRNA is regulated by the 5’ untranslated region which offer alternative 
starting points [96,97]. Emerging relevance of microRNA-155 (miR-155) as negative 
regulator of SOCS1 has been recently published [98-103]. Depending on the cell 
type mIR-155 inhibits the transcription or the translation of SOCS1 [102]. Expression 
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of miR-155 is induced by toll like receptor (TLR) signals (TLR2, 3, 4 and 9) and by 
stimulation (IL-1, tumor necrosis factor α (TNFα), phorbol 12-myristate 13-acetate 
(PMA), IFNβ and γ) indicating that this SOCS1 modulator is expressed in the context 
of inflammation [104-108].  
It has been shown that the SOCS box domain of SOCS1 plays a role in the stability 
of the protein. A SOCS box deletion mutant of SOCS1 was protected from 
proteasomal degradation [109-111]. This phenomenon is probably due to the fact 
that the ubiquitin machinery is not able to bind the SOCS box deleted mutant of 
SOCS1 [70,112]. In line with this concept, once the SOCS1 SOCS box is 
phosphorylated by the Pim family serine/threonine kinase the binding of the ubiquitin 
machinery is blocked resulting in prolongation of the half-life of the protein [113]. 
 
3.2.3.2 SOCS3 
Expression of SOCS3 is induced particularly but not exclusively by IL-6 and type I 
IFN (Table 3.1). In mice it has been shown that SOCS3 knock-out mice died in 
embryonic state due to placenta dysfunction [114,115]. Conditional knock-out of 
hematopoietic cells in mice has been correlated with overactivation of STAT3 in 
response to IL-6 and led to development of neutrophilia and general inflammation 
[116].  
SOCS3 is mainly transcribed by STAT1 and STAT3 [117,118], although other 
transcription factor like Sp3 have been shown to play a role [119,120] via binding to a 
GC-rich motive in proximity of the TATA-box on the promoter [121]. Identical to 
SOCS1, SOCS3 transcription is activated by CpG methylation within the promoter. 
Under stress conditions, for example upon viral infection, SOCS3 mRNA can be 
translated from different starting codon increasing the translation level of the protein 
and its stability, without compromising its activity [122]. The stability of the protein is 
in addition mediated by the SOCS box. Modulation of the half-life of SOCS3 has 
been shown to be dependent on the binding of ubiquitin machinery to the SOCS box 
with considerable extension of the half-life of the protein through stabilization of the 
complex [110,123,124]. Moreover SOCS3 is the only SOCS protein containing a 35 
amino acid PEST [125] (Proline (P), Glutamate (E), Aspartate (D), Serine (S) and 
Threonine (T)) motive which has been described to be recognized as a site for 
protein degradation [126] and has been found to be responsible for the cellular 
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turnover of this protein. In fact, removing PEST drastically increased the half-life of 
SOCS3 without compromising its activity [125]. 
 
3.2.3.3 CIS and SOCS2 
CIS and SOCS2 have a similar function as they both target STAT5, although not 
exclusively. CIS has been shown to bind to the STAT5 binding sites of the receptors 
and thus inhibiting the activation of the transcription factor. CIS is involved in the 
ubiquitination process and consequent degradation of the EPO receptor [127].  
SOCS2 was found to bind to the GH receptor inhibiting the binding and activation of 
STAT5β [128]. SOCS2 knock out mice showed increased body weight suggesting 
the inability of these mice to control GH signaling [129-131]. 
 
3.2.3.4 Other SOCSs 
Not much is known about the remaining SOCS family members. Biological function 
of SOCS4, SOCS5, SOCS6 and SOCS7 remains poorly defined. SOCS4 and 
SOCS5 have been found to be expressed at high levels upon stimulation with EGF. 
SOCS5 upregulation correlates with EGF receptor degradation [132]. SOCS5 is 
induced via IL-6 signaling [133]. Knock-out mice for SOCS6 have a mild growth 
defect implying a possible role for SOCS6 in the control of GH signaling [134]. 
SOCS6 and SOCS7 were found to bind regulatory subunits of phosphatidylinoitol 3 
kinase pathways with a possible role in the control of insulin signaling [134,135]. 
 
 
3.2.4 Role in viral infection  
The role of SOCS proteins in the context of viral infection is an emerging field [74]. A 
number of viruses have been found to upregulate these proteins, especially SOCS1 
and SOCS3, to their advantage (listed in Table 3.2) [74,136-151]. Modulation of 
SOCS proteins correlate with an enhanced infectivity and replication capacity mainly 
by attenuating the activation and the production of type I and II IFNs [74]. The IFNs 
represent a primordial JAK/STAT dependent, tightly regulated defense system 
against acute viral infection and belong to one of the most important antiviral cytokine 
families (Figure 3.3) [152].  
Two members of the herpesvirus family exploit these proteins: Herpes simplex virus 
1 (HSV-1) has been found to upregulate SOCS1 and SOCS3 to counteract type I 
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and type II IFN signaling [140-143]. Interestingly the induction of SOCS1 and SOCS3 
is highly cell specific. After HSV-1 infection, SOCS1 has been found to be 
upregulated in keratinocytes but not in fibroblast. SOCS1 was found to be essential 
for the control of the type II IFN pathway [140]. In cells that upregulate SOCS3 
expression upon HSV-1 infection, silencing of the protein led to a reduction of viral 
progeny titer produced, thus reducing the replication efficiency [142]. The ability of 
the virus to escape type I IFN cell response has been linked to the upregulation of 
SOCS3 [141]. 
 
Table 3.2: Viruses known to exploit SOCS for their advantage (adapted from ([74]) 
Abbreviation: CT-1, cardiotrophin-1; other explained in the text and in the abbreviation list. 
 
 
A further member of the herpesvirus family, Epstein Barr virus (EBV), upregulates 
SOCS3 to its advantage. EBV was first described to upregulate mRNA of SOCS1 
and SOCS3 in infected cells, but no mechanism involving SOCS was assessed 
[153]. Recently, primary monocytes infected with EBV were demonstrated to 
upregulate SOCS3 and to lesser extent SOCS1 mRNA and proteins. The EBV 
protein Zta activated SOCS3 expression which led to the suppression of IFNα 
secretion and favored a state of type I IFN irresponsiveness by downregulating 
STAT2 phosphorylation [139].  
To date only two studies have shown a link between modulation of SOCS and 
HCMV. These studies were carried out in monocytes or monocyte-derived dendritic 
cells (MoDCs). Both investigations showed upregulation of SOCS3 correlated with 
the control of cytokine expression [154,155]. The first study was carried out in 
monocytes and focused on the ability of cmvIL-10 (a homologous to human IL-10) to 
Dissertation 
 
 
Olmo Sonzogni • July 2012 26 
suppress cytokine secretion of cells. Cells were not infected but stimulated with 
cmvIL-10. This report showed that cmvIL-10 inhibits NF-κB activation by reducing the 
degradation of NF-κB inhibitor IκB-α and consequently reduced the expression of 
NF-κB transcribed genes (e.g. TNFα, IL-1β). In this context an upregulation of 
SOCS3 mRNA upon human IL-10 stimulation was detected (which was already 
published [156-158]), whereas protein modulation was not assessed. Upregulation of 
SOCS3 mRNA was not directly linked to NF-κB inhibition. The authors pointed out 
the ability of cmvIL-10 to induce expression of negative immunoregulators like 
SOCS3 [154]. 
More recently, in late 2011, a publication on MoDCs and CMV showed that CMV 
infection of MoDCs (CMV-MoDCs) resulted in mRNA upregulation of SOCS1 and 
SOCS3. Expression of SOCS3 was linked to IL-6 stimulation. It was reported that the 
GM-CSF signaling was impaired in the whole population of CMV-MoDCs, although 
only half of the cells were productively infected. IL-6-induced SOCS3 was at least 
partially responsible for blocking GM-CSF mediated STAT5 signaling in CMV-MoDCs 
since silencing of SOCS3 lead to the rescue of STAT5 phosphorylation. SOCS1 was 
not involved in this process [155]. 
In both reports SOCS3 was claimed to be at least partially involved in HCMV 
mediated mechanism of immunosuppression but no direct link between SOCS3 and 
replication ability of HCMV was provided [154,155]. 
 
3.2.5 Porcine SOCSs 
Porcine SOCS genes and proteins are poorly characterized so far. It is known that all 
the 8 components of the SOCS protein family (CIS, SOCS1, SOCS2, SOCS3, 
SOCS4, SOCS5, SOCS6, SOCS7) are expressed as mRNA at a constitutive level in 
porcine tissues. Interestingly, SOCS1, SOCS3, SOCS7 and CIS were found to be 
expressed at variable constitutive levels in the different tissues analyzed, whereas for 
SOCS2, SOCS4, SOCS5 and SOCS6 the expression levels were less variable [159]. 
Expression of porcine SOCS1 was found to be increased upon infection or 
vaccination against porcine reproductive and respiratory syndrome virus [160,161]. 
Infection with Salmonella enterica, Serovar choleraesuis and typhimurium increased 
expression of porcine SOCS1 [162]. Porcine SOCS2 has been cloned [163] and its 
expression was induced in the epithelium in response to Entamoeba histolytica [164]. 
Porcine SOCS3 mRNA expression was increased by butyrate [165] and decreased 
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by Pasteurella multocida toxin resulting in an constitutive activation of STATs [166]. 
SOCS3 expression in muscle and adipose porcine tissues was found to be related to 
obesity via control of activation of insulin-like growth factor I, which is involved in both 
muscle development and adipose metabolism. The different SOCS3 transcription 
profiles between obese and lean pig in muscle and adipose tissue were correlated 
with the different fat depositions and muscle development [167,168]. 
 
3.3 Aim of the study 
 
SOCS proteins are powerful controllers of JAK/STAT related pathways. These 
proteins are exploited by numerous viruses to control the immunoresponse to their 
advantage. 
 
We hypothesized that interference of HCMV with SOCS proteins results in an 
attenuation of the cellular immune response to the advantage of HCMV. 
  
To test this hypothesis in our endothelial model of HCMV infection a step-wise 
experimental approach was designed: 
• Examination of SOCS1 or SOCS3 modulation upon HCMV infection, on the 
mRNA and protein level. 
• Silencing of SOCS1 and SOCS3 to evaluate the impact on the replication 
efficiency of HCMV. 
• Investigation and elucidation of potential molecular mechanisms underlying 
the HCMV-SOCS interaction. 
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4.  Results part I 
This part is summarizing the development of the thesis in a chronological order. It 
includes unpublished results, problems and troubleshooting that have arisen during 
the work and all the steps that finally led to the results included in the manuscript and 
presented in results part II (Chapter 5). 
Material and methods are included in the chapter 5, section 5.6. Other protocols not 
described in section 5.6 are included in section 4.3. 
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4.1 Porcine setting 
This part of the project was based on a previous thesis carried out in our Lab by 
Maddalena Ghielmetti [169]. She established a real time polymerase chain reaction 
(RT-PCR) multiplex system specific for porcine SOCS1 or SOCS3, which was used 
to measure mRNA expressions. 
 
Figure 4.1: SOCS1 mRNA expression is upregulated by HCMV infection in primary 
PAEC-KO as from 24 hours p.i. 
Time course analysis of TB40/E-infected PAEC-KO (multiplicity of infection (MOI) of 1) show 
an upregulation of SOCS1 (black) transcription starting 24 hours p.i. (A, B and C). In contrast 
SOCS3 (gray) mRNA expression was not modulated upon infection. (Mean with standard 
deviation (SD) of one representative experiment carried out in duplicate (A and C), Mean of 
two independent experiments (B). Results are related to the non-infected control (mock) and 
are normalized to GAPDH expression. 
 
4.1.1  Detection and modulation of SOCS1 and SOCS3 in HCMV-
infected porcine cells 
HCMV productively infects porcine endothelial cells [26,27]. It is expected that after 
xenotransplantation of porcine grafts into human recipients, HCMV is reactivated due 
to the immunosuppression needed. SOCS1 and SOCS3 are strong negative 
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modulator of cytokine pathways that are known to play an important role in rejection 
process (i.e. IFNγ; IL-6). Based on the RT-PCR system established in our lab [169] 
we investigated the expression of SOCS1 and SOCS3 transcripts in HCMV infected 
pECs.  
We first carried out a time course with primary porcine aortic endothelial cells knock-
out for α1,3 galactosyltransferase (PAEC-KO, Figure 4.1A). This analysis showed a 
10 times higher expression of SOCS1 mRNA 24 hours p.i. as compared to non-
infected (mock) PAEC-KO (Figure 4.1A and 4.1B). SOCS1 transcription in HCMV 
infected PAEC-KO increased during the course of infection as shown in figure 4.1C, 
whereas no modulation of SOCS3 mRNA transcription was observed. 
Other porcine endothelial cell lines were analyzed for HCMV mediated modulation of 
SOCS1 or SOCS3 mRNA. The time course experiments (same time points as figure 
4.1A and C) did not show any clear modulation of SOCS1 or 3 transcripts in both 
2A2 (bone marrow derived endothelial cells) or PEDSV.15 (endothelial cells from 
aortic origin) [170]. Reanalysis of one time point are shown in figure 4.2 were the 
mean of two independent experiments indicates no modulation of SOCS1 or SOCS3 
transcription 24 hours p.i.. 
 
Figure 4.2: Cell-specific modulation of 
SOCS1 and SOCS3 in HCMV-infected 
porcine endothelial cell lines 
2A2 (A) and PEDSV.15 (B) immortalized 
porcine endothelial cells were infected for 
24h with TB40/E at an MOI of 1. Analysis 
of SOCS1 (black) and SOCS3 (gray) 
mRNA expression showed no significant 
viral mediated modulation. Shown are the 
means with SD of two independent 
experiments. Results are related to the 
non-infected control (mock) and are 
normalized to GAPDH expression. 
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Based on the results obtained with HCMV-infected PAEC-KO on the mRNA level 
proteins were analyzed by western blot. Figure 4.3 shows SOCS1 and SOCS3 
protein in infected and stimulated cells respectively. Cross-reactivity of both SOCS1 
and SOCS3 antibodies for porcine proteins primarily designed against human 
proteins was established first. A remarkable upregulation of SOCS3 was detected in 
cells stimulated with TNFα, Lipopolysaccharide (LPS) or PMA. SOCS1 seemed to be 
slightly modulated by PMA stimulation although the staining for SOCS1 remained 
inconsistent rendering interpretation difficult. In summary, HCMV infected PAEC-KO 
did not show an obvious viral mediated modulation of both SOCS1 and SOCS3 
(Figure 4.3). 
 
Figure 4.3: Detection of SOCS1 and SOCS3 proteins in PAEC-KO 
Western blot analysis of PAEC-KO revealed no modulation of SOCS1 (A) in cells infected 
with TB40/E (MOI of 1 or 5). Stimulation with PMA (500ng/ml) slightly upregulated SOCS1 
expression. SOCS3 (B) was not modulated by the infection (TB40/E MOI of 1 or 5 and 
TB40/F MOI of 1 or 4). Strong upregulation of SOCS3 was observed if cells were stimulated 
with PMA (500ng/ml), TNFα (100U/ml) or LPS (100ng/ml). HeLa cells lysate was used as 
positive control. 
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4.2 Human setting 
The interesting results obtained in the porcine setting prompted us to broaden the 
range of our research. Since no data were published about a possible interaction 
between HCMV and SOCS in human cells we decided to focus our efforts on this 
topic. The project, which was developed initially within a cross-species 
xenotransplantation context, now included studies of HCMV in cells of the same 
species. 
The results presented in this part are the summary of the results obtained in the 
human setting and describe the work leading to the submitted manuscript. The paper 
contains the essence of the findings and is presented in the next chapter (Chapter 5). 
 
 
Figure 4.4: Detection and modulation of SOCS1 and SOCS3 mRNA in fibroblast 
MRC5 were stimulated with either IFNγ (100U/ml) or PMA (500ng/ml) at the given time points. 
mRNA expression of SOCS1 (black) and SOCS3 (gray) was upregulated by both stimuli. 
Results are related to the non-treated control (mock) and normalized to GAPDH expression. 
Shown is the mean with SD of one representative experiment carried out in duplicate. 
 
4.2.1 Upregulation of SOCS1 and SOCS3 in human cells upon 
stimulation 
To evaluate the expression of SOCS1 and SOCS3 in human cells and to validate the 
RT-PCR system, human lung derived fibroblast (MRC5) were stimulated with PMA 
and IFNγ, two inducers of SOCS1 and SOCS3 [93,171]. MRC5 reacted to both 
stimuli by upregulating the expression of both transcripts reaching the highest level at 
3 hours post stimulation (p.s.) for IFNγ with about 100 and 50 times more mRNA 
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expression of SOCS1 and SOCS3, respectively, as related to the non-stimulated 
control. With PMA upregulation reached the top level as well at 3 hours p.s. with an 
increase of about 15 times for SOCS1 and 50 times for SOCS3 (Figure 4.4). 
After these first results obtained with MRC5, a cell line with the advantage of rapid 
growth and uncomplicated handling, the decision was taken to analyze SOCS1 and 
SOCS3 expression in primary endothelial cells. These cells were chosen for their 
important anatomical location since they form the first barrier between recipient blood 
and transplanted graft. They are known natural targets of HCMV infection. We 
stimulated human primary lung-derived endothelial cells (HMVEC) with IFNβ (Figure 
4.5), IFNγ (Figure 5.1A and C, Chapter 5), PMA (Figure 5.1B and D, Chapter 5),  
 
 
Figure 4.5: Stimulation with IFNβ  of HMVEC modulates SOCS1 and SOCS3 expression 
Time course analysis of HMVEC stimulated with 100U/ml IFNβ resulted in a slight 
upregulation of mRNA expression of SOCS1 (black) and SOCS3 (white). mRNA expression 
levels are related to the untreated control and normalized to GAPDH expression. Shown is 
one representative experiment (A). SOCS3 protein was upregulated whereas SOCS1 protein 
did not show any increase (B). 5 hours p.s. cells were washed and incubated in normal 
medium for 15 more hours showing that SOCS1 and SOCS3 expression is reduced to the 
constitutive level within 15 hours. 
 
TNFα and LPS. SOCS1 and SOCS3 mRNA were both modulated by IFNβ, IFNγ and 
PMA whereas no modulation was observed within the first 5 hours of stimulation with 
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TNFα or LPS (data not shown). Interestingly, although mRNA upregulation of both 
SOCS1 and SOCS3 with IFNβ was lower than what was observed for IFNγ or PMA, 
we obtained exactly the same pattern on the protein level, where SOCS3 was in line 
with mRNA and increased over time. On the contrary, SOCS1 did not show any 
increase on the protein level or even a slight decrease, despite enhanced mRNA 
expression (Figure 4.5 and Figure 5.1, Chapter 5). 
 
4.2.2 Detection and modulation of SOCS1 and SOCS3 in HCMV-infected 
human cells 
Establishment of the RT-PCR system with stimulated samples and verification of the 
expression and modulation of SOCS1 and SOCS3 was followed by a time course 
analysis of HCMV infection in three different cell types. Primary HMVEC and aortic 
endothelial cells (HAEC) and immortalized MRC5 were used (Figure 4.6). The results 
revealed a different pattern of modulation for the three cell types. HMVEC (Figure 
4.6A) showed a 12-fold upregulation of SOCS1 at 10 hours p.i. after HCMV infection, 
whereas SOCS3 was found to be slightly upregulated 2 hours p.i., although SOCS3 
modulation was not consistently observed (Figure 4.6A, Figure 5.2, Chapter 5). 
HAEC (Figure 4.6B) showed an upregulation of SOCS1 already 2 hours p.i., which 
was weaker then the one observed for HMVEC and much less reproducible. SOCS3 
did not show any remarkably modulation. In MRC5 (Figure 4.6C) neither SOCS1 nor 
SOCS3 were strongly modulated. Based on these results and on other similar 
experiments we decided to further investigate the role of HCMV in HMVEC. 
Reproduction of the time course analysis of HCMV infected HMVEC consistently led 
to an upregulation of SOCS1 mRNA between 7 and 12 hours p.i. and these primary 
endothelial cells were the most relevant for our model. 
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Figure 4.6: Time course expression of 
SOCS1 and SOCS3 mRNA in HCMV-
infected human cells 
Time course analysis of HMVEC (A), 
HAEC (B) or MRC5 (C) infected with 
HCMV showed upregulation of SOCS1 
(black) mRNA for the endothelial cells at 
10 hours p.i. for HMVEC and at 2-3 hours 
p.i for HAEC, with a maximum 12-fold and 
8-fold increase, respectively. In MRC5 
infection did not induce any strong 
modulation of the transcripts. SOCS3 
(gray) was not modulated by infection in 
none of the cells tested. mRNA expression 
levels are related to the non-infected 
control (mock) and normalized to GAPDH 
expression. Shown is the mean with SD of 
one representative experiment carried out 
in duplicate. 
 
 
4.2.3 Silencing of SOCS1 and SOCS3 in HMVEC leads to impaired 
HCMV replication 
Silencing of primary cells has always been a challenge due to their refractory nature 
to transfection and their fragility. HMVEC were transfected with short interfering RNA 
(siRNA) targeting SOCS1 (siSOCS1), SOCS3 (siSOCS3) or a scramble non-specific 
control (siCNTR) (Santa Cruz Biotechnology, Heidelberg, Germany). The magnitude 
of the silencing was difficult to assess on the protein level. SOCS1 was undetectable 
for most of the time points in both siSOCS1 and siSOCS3 populations indicating 
possible cross-reactivity of the siRNAs. Most importantly, infected siSOCS1 and 
siSOCS3 cultures resulted in lower viral antigen production compared with siCNTR 
and the non-transfect (N.T.) cultures (Figure 4.7).  
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Figure 4.7: Silencing of SOCS1 and SOCS3 lead to lower viral antigen production in 
HCMV infected HMVEC 
Silencing of SOCS1 and SOCS3 abrogated IE and E antigen production in HMVEC for both 
MOI of 1 and MOI of 5 inoculums compared to cultures transfected with an unspecific siRNA 
and N.T. cells. Lysates were collected either 4 days post transfection/2 days post infection (4 
days p.t., 2 days p.i.) or 6 days post transfection/4 days post infection (6 days p.t., 4 days p.i). 
 
To evaluate the impact of SOCS1 and SOCS3 knock-down on HCMV replication, 
titration of the supernatant for the different conditions was carried out. Figure 4.8 
showed that silencing of SOCS1 and SOCS3 had a significant effect on the 
infectious particles produced in these cultures. siSOCS3 virus titer was reduced by 
10 fold as compared to the one collected in siCNTR or non transfect cultures. 
siSOCS1 resulted in a 5 fold decrease for both multiplicity of infection (MOI) of 5 
(Figure 4.8A) or MOI of 1 (Figure 4.8B). The effect of silencing is limited by many 
factors including metabolism of the cells, magnitude of expression of the target 
genes, stability of the siRNA. Since determination of the silencing rate by western 
blot was difficult, HMVEC were transfected a second time 4 days after the first 
transfection to evaluate the impact of a second silencing on viral replication. 
Analyses of viral antigen production (not shown) were in line with the results found 
for cultures transfected once (Figure 4.8) despite a tendency of twice transfected 
siSOCS3 to even further decrease the viral titer. The fact that the double transfection 
did not increase the effect on the viral replication suggested that the single silencing 
was still effective 5 days p.i.. 
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Figure 4.8: Reduced HCMV infectious viral particles production in siSOCS1 and 
especially siSOCS3 HMVEC 
HCMV titer collected in cells infected with MOI of 5 (A) or MOI of 1 (B) was reduced in 
siSOCS1 and more evidently in siSOCS3 HMVEC. Shown are the results for HMVEC 
transfected once (single transfection ST) or twice (double transfection DT). In both cases 5 
days p.i. the magnitude of the reduction in the titer was about the same, with a tendency of 
increase in siSOCS3 DT. Shown is the mean with SD of one representative experiment 
carried out in duplicate. 
 
 
4.2.4 Optimization of the silencing and western blot technique reveal 
IFN type I activation in silenced HMVEC 
Despite our data indicating a role for SOCS1 and especially for SOCS3 in HCMV 
replication in HMVEC, the results raised a number of questions. In particular, the 
issue related to the determination of the magnitude and specificity of the silencing by 
western blot was not resolved satisfactorily. Optimization of the western blot 
analyses for SOCS1 and SOCS3 were carried out first by quantification of the cell 
lysate with a nanodrop instrument. To assess the reliability of this device and 
Dissertation 
 
 
Olmo Sonzogni • July 2012 38 
compatibility with our lysis buffer (LB), titration of bovine serum albumin (BSA) diluted 
with the LB was  
 
carried out. Figure 4.9A shows that despite a difference between the expected 
concentration (based on the stock concentration of the BSA) and the one measured 
with the nanodrop instrument the error between the two values was constant in a 
range from 3 to 0.3µg/µl. Using this technique of quantification we were able to load 
the same amount of lysate in all the slots of the sodium dodecyl sulfate 
polyacrylamide gel (SDS-Gel) avoiding variation of intensity of the bands due to 
slightly different amount of proteins loaded. After establishing the protocols with the 
nanodrop instrument, the silencing experiments were reanalyzed for SOCS1, 
SOCS3. The results showed that siSOCS3 led to SOCS3 downregulation but also to 
a lower SOCS1 expression. siSOCS1 in contrast showed a specific downregulation 
of the target protein (Figure 4.9B). A crucial additional analysis was performed by 
measuring Mx expression. Mx is an indicator for the activation of type I IFN pathway 
which is a very potent natural inhibitor of viral replication. We had to carefully rule out 
that the observed reduction in HCMV antigen and titer was a mere result of an 
unspecific antiviral state provoked by silencing. Indeed, analysis of Mx expression 
revealed an unexpected induction of this protein for both siSOCS1 and siSOCS3 
samples (Figure 4.9B).  
Abolishing the induction of Mx was mandatory to validate the results collected with 
the virus and for this aim many different strategies and compound for the transfection 
were evaluated. All the experiments previously described were carried out following 
the so-called forward transfection, basically adding the transfection reagent to the 
monolayer of cells. In figure 4.9C different transfection compounds were tested for 
reverse transfection, such that the cells were seeded on the transfection solution. 
Lipofectamin 2000, the compound we usually employed, always gave a strong 
induction of Mx, whereas with HiPerFect and Lipofectamin RNAiMax, Mx was 
basically not detected. Unfortunately, the level of silencing detected for the target 
protein was also reduced (Figure 4.9C). Forward transfection with HiPerFect did not 
lead to better silencing results and showed induction of Mx (Figure 4.9D). 
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Figure 4.9: Protein quantification, western blot optimization and detection of Mx in 
transfected HMVEC 
(A) Reliability of nanodrop protein quantification was evaluated with a titration of BSA diluted 
in the usual LB. The expected results (red) based on the stock concentration of the BSA were 
always higher then the measured results (blue) with an error (green) that was constant until 
very low protein concentrations. (B) Forward transfection with Lipofectamin 2000 lead to Mx 
expression. (C) Reverse transfection with different compounds did not show any remarkable 
silencing for HiPerFect and Lipofectamin RNAiMax; whereas for Lipofectamin 2000 silencing 
and Mx induction were both detected. Forward transfection with HiPerFect led to Mx induction 
without increasing the level of silencing.  
 
 
4.2.5 Establishment of a lentiviral transduction system for efficient 
delivery of short hairpin RNA targeting SOCS1 and SOCS3 
To overcome Mx induction, simultaneously with the different compound and 
transfection strategies, a lentiviral transduction system for delivery of short hairpin 
RNA (shRNA) was designed and developed as originally described by [172] and 
further developed by [173]. This technique offered a number of advantages 
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compared to normal transfection. First the vector expressing shRNA was integrated 
into the genome of the transduced cells allowing longer expression of the silencing 
system. It is much less toxic for the cells than any transfection compound and carried 
a green fluorescence protein (GFP) coding box allowing the determination of the ratio 
of transfected cells by fluorescence microscopy. The system is based on three 
vectors, which were transfected into 293 HEK cells leading to the production of 
lentiviral particles carrying the shRNA expressing vector with the GFP-box.  
 
Figure 4.10: Lentiviral transduction of HMVEC 
Lentiviral particles were collected from 293 HEK cells and added undiluted (A) or diluted 1 to 
10 (B) to HMVEC. Shown are the pictures of the cultures 3 days post transduction, overlay of 
GFP signal and phase contrast microscope pictures. 
 
Supernatant of 293 HEK cells, containing wild type lentiviral particles was collected 
and added undiluted or 10-fold diluted to HMVEC to assess the ability of the 
pseudoviral particles to efficiently transduce this type of cells. Figure 4.10 shows the 
GFP expression in HMVEC 3 days post transduction demonstrating for the first time 
that HMVEC are transducible with this lentiviral system. No previous study has 
shown efficient transduction of HMVEC with this combination of vectors. Two 
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SOCS1, one SOCS3 and a scramble shRNA were designed targeting regions of the 
mRNA that had been shown to be well accessible for the silencing machinery. The 
sequences were cloned into the delivery vector as described in section 4.3.2. After 
the packaging, HMVEC were finally transduced with the vectors containing the 
specific sequences targeting SOCS1 or SOCS3. 
Analysis by western blot (Figure 4.11) unfortunately showed no specific 
downregulation of the target proteins for none of the designed shRNAs. Mx was 
expressed by HMVEC 2 days after transduction and in a reduced amount 6 days 
post transduction in shSOCS1_127 and shSOCS1_822 only (Figure 4.11). 
Quantification by titration of the lentiviral particles based on GFP output allowed the 
optimization of the dilution rate of lentiviral particles stock solution resulting in 80-
90% transfection efficiency (based on GFP expression) and no induction of Mx 
expression.  
Despite non-detectable downregulation of the target proteins HCMV infection of 
shRNA transduced HMVEC were carried out. As expected no modulation of any viral 
antigen was observed (data not shown).  
 
Figure 4.11: Lentiviral transduction of shRNA targeting SOCS1 or SOCS3 does not 
show any specific downregulation 
HMVEC were transduced with shSOCS1_187, shSOCS1_822, shSOCS3, unspecific shRNA 
sequence (shCNTR) or not transduced. Results 2 and 6 days post transduction show no 
specific downregulation of the target protein. Mx was detected 2 days post transduction in 
remarkable amount whereas 6 days post transduction only a weak Mx signal was observed in 
cultures transfected with shSOCS1_187 and shSOCS1_822. 
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4.2.6 Silencing of the target protein without Mx induction 
Finally, new siRNA were purchased form a different company (Invitrogen) and 
transfection were carried out with Lipofectamin RNAiMax, the transfection reagent 
that, based on our experiments appeared to have the best transfection efficiency with 
the lowest toxicity for HMVEC. With this combination we were able to avoid Mx 
induction with remarkable downregulation of the target proteins (Figure 4.12 and 
Figure 5.3A, Chapter 5). In addition the specificity of siRNA appeared to be higher 
than what had been observed for earlier siRNA. This setting was used for all the 
silencing experiment included in the Chapter 5.  
 
 
Figure 4.12: Silencing of SOCS1 and SOCS3 without activation of type I IFN pathway 
HMVEC were transfected with Lipofectamin RNAiMax and siRNA from Invitrogen targeting 
SOCS1 or SOCS3. The western blot shows specific downregulation of the target proteins and 
basically no induction of Mx protein. 
 
 
4.3 Additional material and methods 
Material and methods mentioned in the results part II (Chapter 5, section 5.6) are not 
listed here.  
 
4.3.1 Real Time PCR system for the porcine setting 
RNA extraction and reverse transcription were performed as described in the results 
part II section 5.6. A real time multiplex system was employed [169] to investigate the 
expression of SOCS1 (Fw. 5’-GGAACTGCTTCTTCGCCCTC-3’; Rv. 5’-
GAAGCGGCCGGCCTGG-3’, probe 5’-FAM-TTGTGGGGCCCGAAGCCAT-BHQ1-
3’), SOCS3 (Fw. 5’-CCAACGTGGCCACTCTC-3’, Rv. 5’-
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AGCTGGGTGACTTTCTCATAGGAGTC-3’, probe 5’-FAM-
AACAGTCAACGGCCACCTG-BHQ1- 3’) and GAPDH as housekeeping gene (Fw. 
5’-ACATGGCCTCCAAGGAGTAAGA-3’, Rv. 5’-GATCGAGTTGGGGCTGTGACT-3’, 
probe HEX-CCACCAACCCCAGCAAGAGCACGC-BHQ1). Primers and probes were 
mixed in a multiplex powermix (Biorad) for the detection by RT-PCR. 
 
4.3.2 Lentiviral transduction system 
Lentiviral system [173] was used to deliver shRNA constructs into HMVEC. shRNA 
sequences were self designed and obtained from Microsynth AG (Balgach, 
Switzerland) and are listed below:  
 
After the cloning of the four constructs into the delivery vector (pLVTHM) via the two 
restriction sides MluI and ClaI Polyethylenimine-mediated (jetPRIME™, Polyplus-
transfection® SA, Illkirch, France) co-transfection of 293HEK cells with Gag/Pol 
(pcMVΔR8.91), Env (pMD-2), and either shSOCS1_127, shSOCS1_822, shSOCS3 
or shCNTR constructs cloned into a GFP coding vector (pLVTHM). The wild type 
plasmids were obtained from Prof. Dr. Roberto Speck, (University Hospital Zurich, 
Switzerland). Pseudoviral particles were harvested 48 hours after transfection, 
transferred to Amnicon Ultra 15 ultracell (0.22 m/100kDa) falcon tubes and filtered by 
centrifugation 4000g for 15 minutes, and immediately used for transduction of 
HMVEC. 
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4.3.3 Additional reagents 
For the detection of porcine SOCS by western blot the following antibodies were 
used: SOCS1 antibody (sc-9021, Santa Cruz Biotechnology) and SOCS3 antibody 
(#2923 Cell Signaling). 
Transfection of HMVEC with siRNA has been tested with HiPerFect (Qiagen), 
Lipofectamin 2000 (Invitrogen) in both forward (cells are seeded and the transfection 
reagent was added to the monolayer) or reverse (first transfection reagent to the well 
and then cells were added) transfection protocol. 
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5.  Results part II 
This part includes the manuscript recently submitted. This chapter contains the main 
results of the thesis. 
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5.1 Abstract 
Human cytomegalovirus (HCMV) infection in immunocompromised patients is a 
major cause of morbidity and mortality. Suppressor of cytokine signaling (SOCS) 
proteins are very potent negative regulators of the janus kinase/signal transducer 
and activator of transcription (JAK/STAT) pathways and have been described to be 
exploited by a number of viruses facilitating infection and replication by attenuating 
the immune response of the infected cells. The data presented show that efficient 
replication of HCMV in primary endothelial cells is depended on SOCS3 protein. 
Time course analysis revealed an accumulation of SOCS3 in infected cells. Silencing 
of SOCS3 resulted in a partially inhibited production of immediate early, early and 
late viral antigens. Consistently, HCMV titer produced by SOCS3 silenced (siSOCS3) 
cultures were significantly lower as compared to SOCS1 silenced (siSOCS1) or 
control transfected cultures (siCNTR). Impairment of the replication process due to 
SOCS3 silencing occurred after entry since the number of infected cells was identical 
in all three siSOCS1, siSOCS3 or siCNTR cultures. STAT1 phosphorylation was 
increased in siSOCS3 and siSOCS1 infected cells when compared to siCNTR-
treated cells. In contrast, phosphorylation of STAT2 was only increased in siSOCS3 
cultures. Analysis by flow cytometry of the ability of the virus to control IFNβ-inducible 
gene expression showed that the HCMV-infected fraction of siSOCS3 culture had a 
higher percentage of cells expressing IFNβ-induced MHC-I molecules compared with 
siSOCS1 or siCNTR. Thus, these findings demonstrate that SOCS3 plays a critical 
role for efficient HCMV replication in primary endothelial cells and provide evidence 
for an involvement of SOCS3 in HCMV-mediated control of the type I IFN pathway. 
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5.2 Author summary 
Human cytomegalovirus (HCMV) exploits many avenues to evade the immune 
response. Here we present data showing for the first time that efficient replication of 
this virus requires a specific protein called suppressor of cytokine signaling 3 
(SOCS3). This protein is responsible for the attenuation of the cytokine-mediated 
immune response of cells, acting as negative regulator in some of the key pathways 
involved in this process. A number of viruses have already been shown to use 
members of the SOCS family to their advantage. Our data demonstrate that in cells 
with reduced SOCS3 protein expression, HCMV replication is impaired at multiple 
steps resulting in a marked reduction of infectious progeny. We also provide 
evidence that SOCS3 plays a critical role in the ability of HCMV to interfere with the 
immune response. These findings may open new avenues using SOCS3 as a 
possible target aimed at controlling HCMV replication. 
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5.3 Introduction 
Suppressor of cytokine signaling (SOCS) proteins are very potent negative 
regulators of the janus kinase/signal transducer and activator of transcription 
(JAK/STAT) pathways. Eight members of this family have been reported, SOCS1 to 
7 and the cytokine-inducible SH2 domain-containing protein (CIS) [65-67,83].  SOCS 
proteins play an important role in maintaining and restoring homeostasis upon 
cytokines stimulation [75]. They consist of three main domains: the N-terminal which 
is variable in length and sequence; a central SH2 domain and a C-terminal SOCS 
box domain [83]. The SH2 domain binds to the phosphorylated target proteins 
whereas the SOCS box binds to the ubiquitin machinery allowing for 
poliubiquitination and consequently degradation of the target proteins in the 
proteasome. SOCS1 and SOCS3 also contain a kinase inhibitor region which can 
directly inhibit the kinase activity of the target proteins [74,75]. 
The interferons (IFNs) represent a JAK/STAT-depended tightly regulated defense 
system against viral infections [152]. SOCS1 and SOCS3 have been investigated for 
their particular ability to attenuate IFN-mediated responses to viral infections [174]. A 
number of viruses exploit SOCS1 and SOCS3 [74,136-143,145-151,175], including 
members of the herpesviridae like Herpes simplex-1 virus (HSV-1) [13-16] and 
Epstein Barr virus (EBV) [12]. Modulation of SOCS1 and SOCS3 proteins correlate 
with an enhanced infectivity and replication capacity mainly by attenuating the 
activation and the production of type I and II IFNs [74]. 
Human cytomegalovirus (HCMV) is a member of the herpesviridae family. In 
immunocompetent adults the infection is asymptomatic but leads to life-long latency 
and seroprevalence in adults reaches 80%. In immunocompromised patients, such 
as neonates or after transplantation, primary infection or reactivation of this virus is a 
major cause of morbidity and mortality [1]. 
HCMV interference with type I and II IFN activation as a means of immune evasion 
occurs at different stages. The observed effects are highly dependent on the virus 
strain and on the cell type of the model investigated [9]. In the well-characterized 
model of fibroblasts infected with the HCMV Towne strain interference of type II IFN 
responses occurs at different levels after infection, starting with the inhibition of class 
II transactivator expression about 6 hours post infection (p.i.) [36]. This is followed by 
the inhibition of STAT1 phosphorylation by src homology region 2 domain-containing 
phosphatase, at about 16 hours p.i. [37], and finally by JAK1 disruption 72 hours p.i. 
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[38]. Downregulation of IFNγ-induced major histocompatibility complex class II (MHC-
II) expression in HCMV infected cells has also been demonstrated [36,38-41]. As 
JAK1 is a shared component of type I and type II IFN pathways the disruption of this 
protein affects both pathways. Focusing on type I IFN it was additionally shown that 
p48, another key component of this pathway, was targeted in HCMV infected cells. 
[42]. Moreover, HCMV has been found to inhibit type I IFN dependent expression of 
MHC class I (MHC-I), IFN regulatory-1, myxovirus resistance A and 2,5-
oligoadenylate synthetase gene expression in fibroblast and human umbilical vein 
endothelial cells (HUVEC) [9,42], although some of these findings are conflicting as 
others show an upregulation of these genes in HCMV infected fibroblasts [43-49]. A 
decrease in the STAT2 phosphorylation followed by a reduction of the total amount 
of the proteins was recently shown in HCMV infected fibroblast. Degradation of 
STAT2 was found to be strain dependent and not observed for Towne virus [50]. 
HCMV-mediated downregulation of MHC-I and MHC-II has been correlated with the 
ability of the virus to establish latency and escape CD4+ and CD8+ T-cells mediated 
clearance [36,176-179]. Most of the studies published so far on HCMV infection of 
adherent cells were carried out in fibroblasts, or HUVEC. For our studies we chose 
primary human lung-derived microvascular endothelial cells (HMVEC). Being at the 
interface between blood and tissue the endothelium has been shown to be a 
strategic natural site of infection for HCMV in vivo following a primary infection [29-
33] and it is believed to act as viral reservoir [34] involved in viral spread and 
persistence. Virus-mediated changes in the phenotype of infected endothelial cells 
may contribute to the dissemination of the virus into organs and has been associated 
with viral pathogenicity. [35].   
To date only two studies have shown modulation of SOCS3 upon HCMV infection of 
monocytes or dendritic cells and this upregulation was correlated in both cases with 
control of cytokine expression [154,155]. We investigated the role of SOCS1 and 
SOCS3 proteins during HCMV infection of HMVEC. Analyzing HCMV-infected 
HMVEC we show for the first time, that efficient HCMV replication is dependent on 
SOCS3. We present evidence for a role of SOCS3 in HCMV-induced inhibition of 
STAT2 phosphorylation and HCMV-mediated attenuation of type I IFN-induced 
expression of MHC-I molecules, implicating that SOCS3 mediates control of type I 
IFN pathway activation in HCMV-infected endothelial cells. 
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5.4 Results 
 
5.4.1 Detection and modulation of SOCS1 and SOCS3 in HMVEC 
In unstimulated HMVEC, low levels of SOCS1 and SOCS3 mRNA were detected by 
RT-PCR. Stimulation with IFNγ, a strong inducer of SOCS1 and SOCS3 expression, 
increased mRNA transcription reaching the highest levels 5 hours post stimulation 
(p.s.) for SOCS1 and one hour p.s. for SOCS3 (Figure 5.1A). Analysis by western 
blot revealed a parallel increase for SOCS3 protein, whereas no modulation of 
SOCS1 protein was observed (Figure 5.1C). Even when phorbol 12-myristate 13-
acetate (PMA) was used instead of IFNγ, the same pattern was observed despite 
very high mRNA expression levels for SOCS1 (Figure 5.1B and D). For both IFNγ 
and PMA, after removing the stimulus and keeping the cells for 20 more hours in 
normal medium, expression of SOCS1 and SOCS3 mRNA returned to levels 
observed before stimulation, as did SOCS3 protein.  
 
5.4.2 SOCS1 and SOCS3 are modulated by HCMV infection of HMVEC  
Time course analysis of SOCS1 and SOCS33 mRNA expression in HCMV infected 
HMVEC was carried out in cells infected with either a multiplicity of infection (MOI) of 
1 or 5.  Transcription of SOCS1 was induced within 8 and 12 hours p.i. in a MOI-
dependent manner (Figure 5.2A and B). SOCS3 transcription levels, in contrast, 
were not modulated by neither MOI. 
Analysis of SOCS1 and SOCS3 protein levels in HCMV infected HMVEC revealed 
an accumulation of SOCS3 protein starting between 5-10 hours p.i. on (Figure 5.2C), 
whereas for SOCS1 no infection dependent modulation of the protein level was 
observed. The accumulation of SOCS3 was dependent on active viral replication 
since it was not observed when cells were either infected with UV-inactivated virus 
(Figure 5.2D) or not infected (Figure 5.2E). Accumulation of SOCS3 was particularly 
prominent in the late phase of the infection.  
These results demonstrate a modulation of SOCS1 and SOCS3 in HCMV infected 
HMVEC and may indicate an active involvement of these cellular factors in the viral 
replication process. 
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5.4.3 Silencing of SOCS3 leads to impaired HCMV replication in HMVEC 
To investigate the role of SOCS1 and SOCS3 in the context of HCMV infection of 
HMVEC short interfering RNA (siRNA) targeting SOCS1 (siSOCS1), SOCS3 
(siSOCS3) or a scramble, non-specific sequence as negative control (siCNTR), were 
transfected in HMVEC resulting in a reduction of the target proteins of about 40% 
related to siCNTR (Figure 5.3A). Analysis of the infected samples collected 2 (Figure 
5.3B) or 5 days p.i. (Figure 5.3C) revealed a major inhibition of viral antigen 
production in siSOCS3 cells. Mainly the early (E) and the late (L) viral proteins were 
affected by SOCS3 silencing. 
Titration of the supernatants collected 5 days p.i. showed a significant reduction in 
the number of infectious particles produced by siSOCS3 cultures compared with 
siSOCS1 and siCNTR cultures for both MOI of 1 and MOI of 5 (Figure 5.3D). 
These results further point to an active involvement of SOCS3 during HCMV 
replication in HMVEC. The effect of SOCS3 silencing is more prominent during the 
late phase of infection. In line with this observation, in cultures transfected just after 
infection we obtained similar results for both viral antigens production and 
supernatants viral titers (data not shown). 
 
5.4.4 Silencing of SOCS3 leads to high level of STAT1 and STAT2 
phosphorylation in HCMV infected HMVEC 
To elucidate the possible mechanisms underlying the impairment of the HCMV 
infection of HMVEC upon silencing of SOCS3 we investigated the activation pattern 
of the different infected cultures (siSOCS1, siSOCS3 or siCNTR) 2 (Figure 5.4A) and 
5 (Figure 5.4B) days p.i. for both MOI of 1 and MOI of 5. For both time points, 
phosphorylation of STAT1 was remarkably increased in siSOCS3 and siSOCS1 as 
compared to the siCNTR cultures. Within the same condition, no differences between 
cultures infected with an MOI of 1 or MOI of 5 were observed for the phosphorylation 
of STAT1. In contrast, STAT2 was found to be phosphorylated only in siSOCS3 
cultures infected with an MOI of 5 for both 2 and 5 days p.i. with an increase in 
phosphorylation of 164% and 171% respectively. Phosphorylation of STAT2 in 
siSOCS1 cultures did not differ from siCNTR cultures (Figure 5.4A and B). These 
differences in the phosphorylation of STAT1 and STAT2 between siCNTR and 
siSOCS3 may indicate a possible implication of SOCS3 in the mechanism that allows 
the virus to control type I and/or type II IFN pathway activation.  
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5.4.5 No differences in type II IFN inducible gene expression between 
siSOCS3 and siCNTR infected cultures 
To evaluate the ability of HCMV to control type II IFN pathway in siSOCS1, siSOCS3 
and siCNTR HMVEC, cells were stimulated 48 hours p.i. for 24 hours with IFNγ. It 
was previously shown that HCMV can decreases expression of IFNγ-induced MHC-II 
molecules [36,38,39]. To measure the capability of HCMV to reduce HLA-DRα 
transcription, mRNA expression of HLA-DRα was quantified in the three different 
cultures (siSOCS1, siSOCS3 and siCNTR). Infection of the cultures decreased the 
transcription of HLA-DRα to about the same level in all 3 conditions (Figure 5.5). 
These results are in line with the literature [36,38,39] and indicate that HCMV can 
control type II IFN pathway independently from SOCS1 or SOCS3. 
 
5.4.6 HCMV needs SOCS3 to control type I IFN inducible gene 
expression 
To evaluate the ability of HCMV to control type I IFN pathway in siSOCS1, siSOCS3 
and siCNTR HMVEC were stimulated 48 hours p.i. for 24 hours with IFNβ. It was 
previously shown that HCMV can lower the expression of IFNβ-induced MHC-I 
molecules [42]. Flow cytometry analysis showed that 3 days p.i the fraction of HCMV 
infected cells was the same in all the three conditions (siSOCS1, siSOCS3 and 
siCNTR, Figure 5.6A, B and C respectively). Analyzing the infected fraction only, it 
was found that the percentage of cells expressing MHC-I molecules was reduced to 
8% in siCNTR and siSOCS1 cultures whereas it was found to be about the double 
(15.3%) in siSOCS3 culture (Figure 5.6D).  
These results indicate that SOCS3 may be used by HCMV to inhibit the expression 
of type I IFN-induced MHC-I molecules in HMVEC.  
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Figure 5.1: Detection and modulation of SOCS1 and SOCS3 in stimulated HMVEC 
Time course analysis of HMVEC stimulated with either 100U/ml IFNγ (A and C) or 500ng/ml 
PMA (B and D) resulted in upregulation of mRNA expression of SOCS1 (black) and SOCS3 
(white) in both conditions. mRNA expression levels are given as percentage related to the 
untreated control (taken as 100%) normalized to GAPDH expression. Shown is the mean with 
standard deviation (SD) of one representative experiment per condition, carried out in 
duplicate (A and B). SOCS3 protein was also upregulated by both stimuli whereas SOCS1 
protein did not show any increase (C and D). 5 hours p.s. cells were washed and incubated in 
normal medium for 20 more hours showing that SOCS1 and SOCS3 expression it is reduce 
to the constitutive level within 20 hours. 
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Figure 5.2: HCMV infection of HMVEC induced SOCS1 mRNA expression and SOCS3 
protein accumulation 
Time course analysis of HCMV-infected HMVEC resulted in an increase of SOCS1 (black) 
mRNA expression within 8 and 12 hours p.i. for both MOI of 1 or 5, whereas no modulation of 
SOCS3 (white) was detected. mRNA expression levels are given as percentage related to the 
non-infected control (taken as 100%) normalized to GAPDH expression. Shown is the mean 
with SD of one representative experiment, carried out in duplicate (A and B). Western blot 
analysis of HCMV infected (C), UV inactivated HCMV infect (D) or not infected (E) HMVEC 
revealed that SOCS3 protein is accumulated only in HCMV infected samples. In contrast, 
SOCS1 was not modulated. 
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Figure 5.3: HCMV infection of HMVEC is impaired upon silencing of SOCS3 
HMVEC were transfected with siRNA targeting SOCS1, SOCS3 and a non-specific control 
(siSOCS1, siSOCS3 and siCNTR respectively), which resulted in a reduction of target protein 
expression of about 40% for both siSOCS1 and siSOCS3 with siCNTR taken as 100% (A). 
After infection with HCMV, siSOCS3 culture showed a reduction in viral antigens (IE, E and L) 
expression 2 days (B) and 5 days p.i. (C) for both MOI of 1 and 5 as compared to siSOCS1 
and siCNTR cultures. The titer of virus produced in siSOCS3 cultures was significantly lower 
than in siCNTR or siSOCS1 cultures for both MOI of 5 (black) and MOI of 1 (white) 
inoculums. Shown are the means with SD of two independent experiments, with *p<0.05 
between siSOCS3 and siCNTR and **p<0.0001 between siSOCS3 and both siSOCS1 and 
siCNTR (D).  
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Figure 5.4: Higher phosphorylation of STAT2 in siSOCS3 HCMV-infected HMVEC  
HMVEC transfected with siSOCS1, siSOCS3 or siCNTR were infected with HCMV. 
Phosphorylation of STAT1 was increased in siSOCS1 and siSOCS3 cells 2 (A) and 5 days 
p.i. (B) for both MOI of 1 and MOI of 5. STAT2 appeared to be phosphorylated only in 
siSOCS3 cultures infected with MOI of 5 with a level that reached 164% and 171% of siCNTR 
phosphorylation at day 2 (A) and day 5 (B) p.i., respectively.  
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Figure 5.5: Reduction of IFNγ-induced HLA-DRα  mRNA expression upon HCMV 
infection is not dependent on SOCS1 or SOCS3 
HMVEC transfected with siSOCS1, siSOCS3 or siCNTR were infected with HCMV at an MOI 
of 5 (samples labeled ‘HCMV’). Non-infected or 2 days p.i. cultures were stimulated for 24 
hours with 100U/ml IFNγ. Transcription of HLA-DRα mRNA was reduced in all samples upon 
infection (light gray columns, infected cultures within the conditions as reference). The 
reduction of HLA-DRα expression reached the same level in all the samples (dark gray 
columns, related to siCNTR HCMV). Shown is the mean with SD of one representative 
experiment carried out in duplicate as percentage to the respective control. 
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Figure 5.6 Reduction of IFNβ-induced MHC-I expression upon HCMV infection is 
influenced by silencing of SOCS3 
HMVEC transfected with siSOCS1, siSOCS3 or siCNTR were infected with HCMV for 48 
hours and then stimulated with 500U/ml IFNβ fro 24 hours. Analyses of the samples by FACS 
revealed that 3 days p.i. the number of cells infected (IE+) was the same for siSOCS1 (A) 
siSOCS3 (B) and siCNTR (C) cultures. Expression of MHC-I within the infected fraction 
(black) revealed that in siSOCS3 cultures the percentage of cells expressing MHC-I is 
increased in comparison to the two remaining conditions (D). MHC-I expression for the total 
population or IE- cells are shown in light and middle gray and demonstrated an expected 
upregulation in all three conditions. 
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5.5 Discussion 
In this study we demonstrated that HCMV needs SOCS3 for an efficient replication in 
HMVEC. We started by investigating the ability of these cells to express and 
modulate the expression of SOCS1 and SOCS3. Stimulation of cells with PMA or 
IFNγ resulted in mRNA increase for both SOCS1 and SOCS3 whereas only SOCS3 
was found to be upregulated on the protein level (Figure 5.1). This apparent 
discrepancy between the mRNA and the protein expression of SOCS1 was also 
found in HCMV infected cells where the virus was able to considerably upregulate 
SOCS1 mRNA between 8 and 12 hours p.i. but no modulation of the protein was 
observed (Figure 5.2).  
A similar phenomenon was recently reported for vesicular stomatitis virus (VSV).  
Cells infected with VSV showed an upregulation of SOCS1 mRNA but not for the 
protein [102]. This result correlated with a negative posttranscriptional regulation of 
SOCS1 translation by microRNA-155 (miR-155). Emerging relevance of miR-155 as 
regulator of SOCS1 has been recently published [98-103]. Expression of miR-155 is 
induced by toll like receptor (TLR) signals (TLR2, 3, 4 and 9) and by stimulation (IL-1, 
TNFα, PMA, IFNβ and γ) indicating that this SOCS1 modulator is expressed in the 
context of inflammation [104-108]. Moreover EBV and Kaposi's sarcoma-associated 
herpes virus (KSHV), two member of the herpesvirus family, have already been 
found to induce expression of miR-155 [180] or to directly express an ortholog to 
miR-155 [181], respectively. We are currently investigating the potential role of miR-
155 in our model. 
SOCS3 mRNA transcription was not modulated by HCMV but an accumulation of the 
protein was observed during infection (Figure 5.2). This accumulation was found to 
be dependent on active replication of the virus since it was not observed in UV-
inactivated HCMV infected culture, where HCMV can enter the cell but cannot 
replicate. Modulation of the half-life of SOCS3 has been shown to be dependent on 
the binding of ubiquitin machinery to the SOCS box with considerable extension of 
the half-life of the protein through stabilization of the complex [110,123,124]. 
Moreover SOCS3 is the only SOCS protein containing a 35 amino acid PEST [125] 
(Proline (P), Glutamate (E), Aspartate (D), Serine (S) and Threonine (T)) motive 
which has been described to be recognized as a site for protein degradation [126] 
and for SOCS3 it has been found to be responsible for the cellular turnover of this 
protein. In fact, removing PEST drastically increased the half-life of SOCS3 without 
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compromising its activity [125]. The exact mechanism of the observed accumulation 
in our model remains open and may involve inhibition of protein degradation. We 
suggest that SOCS3 may be stabilized by the infection through binding, by viral or 
viral modulated cellular factors, of the key regions (i.e. PEST, SOCS box-ubiquitin 
machinery complex) involved in turn over regulation of the protein resulting in an 
elongated half-life and therefore in an accumulation of SOCS3 in infected cells. 
Importance of SOCS1 and SOCS3 for HCMV replication in HMVEC was assessed 
by silencing experiments. Upon silencing of SOCS3, HCMV showed a limited 
replication capacity in HMVEC. Inhibition of IE, E and L viral antigen production was 
observed showing an especially high decrease of L antigen and a partial reduction of 
E antigen whereas IE antigen production was not much impacted (Figure 5.3). In 
accordance, and such demonstrating a profound impact on viable virus, the HCMV 
titer collected in siSOCS3 cultures were significantly reduced in comparison with 
siSOCS1 and siCNTR cultures. These results suggest a possible role of SOCS3 
relatively late in the infection. In line with this, cells transfected just after infection also 
showed a similar reduction of both viral antigens and infectious viral particles 
produced (data not shown). Moreover the ratio of infected cells detected 1 day p.i. 
(data not show) and 3 days p.i (Figure 5.6A, B and C) based on IE staining was the 
same in all the three conditions (siSOCS1, siSOCS3 and siCNTR). These results 
indicate that SOCS3 plays a role only later after infection, since the virus can enter 
and infect the same number of cells in all three conditions.  
Analysis of the activation pattern of infected cultures revealed an increase in STAT1 
phosphorylation for siSOCS1 and siSOCS3 cultures compared to siCNTR (Figure 
5.4), which was stronger 2 days p.i. than 5 days p.i. and did not depend on the MOI 
of the inoculum. These results indicate a possible role for SOCS3 or SOCS1 in type 
II IFN escape mechanism of the virus since STAT1 is a major component of this 
pathway. Therefore we investigated the ability of HCMV to lower the transcription of 
HLA-DRα, an MHC-II gene, upon IFNγ stimulation as shown previously [36,38,39]. 
The results showed a similar ability of the virus to downregulate the expression of 
HLA-DRα in all the three condition (Figure 5.5), indicating that control of at least 
MHC-II gene expression occurs independently from SOCS1 or SOCS3.  
Phosphorylation of STAT2 on the contrary was found to be specific for siSOCS3 
infected cultures and this increase was observed only in cells that were infected with 
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an MOI of 5 indicating a probable relation between STAT2 phosphorylation and 
number of infected cells (Figure 5.4). 
These results suggested an involvement of SOCS3 in the inhibition of STAT2 
phosphorylation by HCMV. Since STAT2 is a major component with STAT1 of the 
type I IFN pathway we decided to evaluate the ability of the virus to control this 
pathway in siSOCS3 cells. To evaluate the impact of STAT2 rescued 
phosphorylation and HCMV ability to control type I IFN pathway in siSOCS3 infected 
cells, we stimulated cells with IFNβ and measured expression of MHC-I molecules 
known to be down regulated in HCMV infected cells [42]. The fraction of infected 
siSOCS3 cells expressing MHC-I molecules was about two times higher compared 
with siSOCS1 or siCNTR (Figure 5.6D). From previous experiments it was known 
that HCMV could inhibit the phosphorylation of STAT2 in TB40/E infected fibroblast. 
In cultures infected at a very high rate even degradation of STAT2 was observed. 
Following restoration of STAT2 expression, phosphorylation and activation by type I 
IFN was still impaired indicating two different layers of HCMV interference with 
STAT2 activation, one controlling the phosphorylation and one degrading the protein 
[50]. Based on our results we suggest that SOCS3 is an important component for the 
HCMV-mediated control of STAT2 phosphorylation. In other studies carried out with 
the Towne strain on fibroblast it has been shown that IE72 interact with STAT2 
[51,182] and implication in the control of STAT2 by IE has been provided. HCMV has 
develop many strategies to control IFN activation [9]. Depending on the cell type and 
on the virus strain these mechanisms vary resulting in a complex multistep process. 
In our model we demonstrate that reduction of SOCS3 not only leads to restoration 
of STAT2 phosphorylation but also increases the response of infected cells to type I 
IFN. These results indicate, for the first time, an involvement of SOCS3 in HCMV 
mediated inhibition of type I IFN pathway and may also suggest a possible role of 
SOCS3 in the process of latency since MHC-I molecules downregulation is essential 
to escape CD8+ T-Cells mediated clearance.  
In summary we describe here for the first time that SOCS3 plays an essential role 
during HCMV replication in primary human endothelial cells. Accumulation of SOCS3 
protein was observed in infected cells and a correlation between SOCS3 and the 
ability of the virus to efficiently replicate was provided. Indications of a SOCS3-
dependend mechanism of HCMV to control type I IFN activation through inhibition of 
STAT2 phosphorylation were given. 
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These findings add a novel aspect to the biology of HCMV and potentially identify 
SOCS3 as novel target protein to control of HCMV viral replication. 
 
 
5.6 Materials and methods 
 
5.6.1 Cells and viruses 
All experiments were carried out in primary human lung-derived microvascular 
endothelial cells (HMVEC, Lonza, Basel, Switzerland) between passage 4 and 8, 
cultured in complete EGM-2 medium (Lonza, Basel, Switzerland). 
All experiment were carried out with the HCMV strain TB40/E [183], kindly provided 
by Dr. Christian Sinzger (University of Ulm, Germany). The virus was propagated on 
human lung-derived fibroblasts MRC5 [184] (LGC Standards, Teddington, UK, 
cultured in Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, Basel, 
Switzerland) containing 10% fetal calf serum (A15-101, lot: A10110-2432, PAA) and 
2mM L-glutamine (Invitrogen). Purification of HCMV was carried out by 
ultracentrifugation over a 15% sucrose cushion (50mM Tris-HCl, 12mM KCl, 5mM 
Na2EDTA) at 20,000g for 90 min at 4°C using an SS-34 rotor (Beckman Coulter, 
Fullerton, CA). The infectious titer in HCMV for the stock virus and for supernatant of 
the experiments was determined by TCID50 assays on MRC5 [185]. As control, 
HCMV was UV-inactivated (5 min, 30 cm distance from a 30W, 230V, 50Hz UV lamp 
(Osram, Winterthur, Switzerland)) [186]. 
HMVEC were infected with either a MOI of 1 or MOI of 5. If not else indicated the 
infection rate was determined one day p.i. by immunofluorescence as previously 
described [26] employing an antibody against immediate early 52, 72 and 86 kDa 
proteins (Ref. 11-003, Argene, Varhiles, France), resulting in about 7-12% of infected 
cells for MOI of 1 and 30-40% for MOI of 5 in all the experiments showed. All cell 
preparations were tested negative by 4, 6-diamidino-2-phenylindole (DAPI; D9542, 
Sigma, Buchs, Switzerland) staining for mycoplasma.  
Cells were stimulated for the period of time indicated for each experiment with 
500ng/ml PMA (Sigma), 100U/ml IFNγ (PeproTech, Rocky Hill, NJ) or 500U/ml IFNβ 
(PeproTech). HMVEC were infected one day post transfection in all the silencing 
experiments.  
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5.6.2 Real-Time PCR 
Total RNA from cells was isolated using RNeasy Mini Kit (Qiagen, Hombrechtikon, 
Switzerland) with DNase (RNase-Free DNase Set, Qiagen) treatment step. 
Superscript III reverse transcriptase (Cat. No. 18080-093, Invitrogen) was used, 
following manufacturer’s instruction, for reverse transcription of the mRNA. cDNA 
was analyzed with Taqman gene expression assays (Applied Biosystem) for SOCS1 
(Assay ID: Hs00705164_s1), SOCS3 (Assay ID: Hs00269575_s1), HLA-Drα (Assay 
ID: Hs00219575_m1) and GAPDH (Assay ID: Hs9999905_m1) using HotStarTaq 
master mix (Qiagen) supplemented MgCl2 (1.5 µM). Amplification of cDNA was 
performed with a real time thermocycler (iQ5 Cycler; Bio-Rad, Reinach, Switzerland) 
as follows: 15 min at 95 °C and 45 cycles of 15 second at 95°C and 60 seconds at 
60°C. GAPDH was used as housekeeping genes [187] to normalize results, data 
were analyzed using the iQ5 Optical System Software (Bio-Rad), and results were 
reported as relative expression levels to the untreated controls. 
 
5.6.3 Western blot 
Western blot analysis of SOCS1 (#3950, working dilution 1/300, Cell Signaling), 
SOCS3 (sc-51699, working dilution 1/500, Santa Cruz Biotechnology, Heidelberg, 
Germany), STAT1P (Tyr701) (sc-136229, working dilution 1/500, Santa Cruz 
Biotechnology) STAT1 (sc-346, working dilution 1/500, Santa Cruz Biotechnology) , 
STAT2P (Tyr690) (#4441, working dilution 1/500, Cell Signaling,), β-Actin (A5441, 
working dilution 1/5000, Sigma) and of the IE (52, 72 and 86kDa proteins, Ref 11-
003, working dilution 1/5000, Argene), E (ICP36, CA006-100, working dilution 
1/10000, Virusys, Taneytown, MD), L (pp65, vp-c 422, working dilution 1/1000, 
Vector Laboratories, Burlingame, CA) viral antigen were carried out as follow. Cell 
lysates were prepared by adding 50 µl of ice-cold lysis buffer (20mM Tris-HCl, pH 
7.5, 150mM NaCl, 1% Tween 20, 1mM EDTA, 0.1% SDS, and protease inhibitor, 
Calbiochem) to the monolayer and collected allowing lysis for 30 minutes. Protein 
concentrations were determined by Nanodrop 1000 spectrophotometer. Everything 
was carried out strictly on ice until SDS sample buffer (50mM Tris–HCl, pH 6.8, 10% 
glycerol, 2% SDS, 5% β-mercaptoethanol, and 0.1% Bromophenol dye) was added 
to the samples which were then boiled at 95°C for 5 minutes. Equal amounts of 
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protein from cell lysates were separated by gel electrophoresis and transferred to a 
polyvinyl membrane (GE Healthcare, Muenchen, Germany). After blocking with 5% 
milk powder (Rapilait, Migros, Switzerland) in 1x Tween 20/Tris-buffered saline (0.1% 
Tween 20, 25 mM Tris–HCl, pH 7.5, and 150 mM NaCl) for 2 h at room temperature, 
membranes were incubated with the primary antibody overnight at 4 °C, followed by 
anti mouse or anti rabbit horseradish peroxidase-conjugated secondary antibody 
(working dilution 1:5000) (GE Healthcare) for 1 h. The target proteins were detected 
by enhanced chemiluminescence using the ECL reagent (GE Healthcare). Signals 
were quantified with the ImageJ analysis software. 
 
5.6.4 Cells transfection 
Small interfering RNA (siRNA) targeting SOCS1 mRNA (HSS189479, stealth RNAi, 
Invitrogen use in the experiment shown and sc-40997, Santa Cruz Biotechnology to 
confirm the results) or SOCS3 mRNA (HSS113313, stealth RNAi, Invitrogen 
experiment shown and sc-41000, Santa Cruz Biotechnology to confirm the results) 
and a scramble non-specific sequence (CNTR-D or A sc-44232 and sc-37007 
respectively, Santa Cruz Biotechnology) were transfected using Lipofectamin 
RNAiMax (Invitrogen) according to the manufacturer’s instructions. Briefly, cells were 
seeded in a 24 well plate. 50 ρmol of siRNA were mixed with 1.5 µl Lipofectamin 
RNAiMax in 100 µl OptiMEM (Invitrogen), incubated for 10 minutes at room 
temperature before adding the mixture to the cells.  
 
5.6.5 Cell staining and flow cytometry  
Cells were harvested with a mild trypsin (Invitrogen, diluted to final concentration of 
0.005% in 0.02%EDTA) treatment. For combined cell surface and IE stainings, cells 
were first stained with PE conjugated mAb to HLA-ABC (G46-2.6, BD Pharmingen, 
San Diego, CA). Next, cells were fixed and permeabilized following the BD 
Cytofix/CytopermTM protocol (Becton-Dickinson), and then incubated with Alexa-fluor 
488 conjugated IE1 mAb (8B1.2, Merck Millipore, Darmstadt, Germany). The PE 
conjugated G155-178 (IgG2ak, BD Pharmingen) and Alexa-fluor conjugated normal 
mouse IgG (IgG, Merck Millipore) were used as isotype-matched controls. The 
fluorescence intensity was measured by using a FACSCanto (BD Biosciences, 
Basel, Switzerland) and analysis was performed using FlowJo software (Tree Star, 
Ashland, OR, USA). 
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5.6.6 Statistical analysis 
Significances of TCID50 values (Figure 3D) were calculated with the Fisher’s exact 
test performed with StatView software (SAS institute Inc., San Francisco, CA) with 
p<0.05 (*) and p<0.0001 (**). 
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6.  General discussion 
 
6.1 Porcine setting 
In the last decades major findings have led to an increased understanding of 
molecular mechanism underlying immunological processes. Together with the 
discovery of potent immunosuppressive compounds, transplantation has become a 
clinical reality. This success has created a new problem: the shortage of organs. 
Alternatives are intensely investigated. Transplantation of pig organs into humans 
has been advocated as a potential solution [188]. Clinical trial are already performed 
using porcine islet cells for diabetic patients [189]. In anticipation of a clinical 
application issues such as compatibility [190] and zoonosis [191] are major hurdles. 
This laboratory established [26] and characterized [27] a model of HCMV infection of 
porcine cells to evaluate the possibility and the impact of a cross species infection. 
Based on the work of Maddalena Ghielmetti [169] who established a RT-PCR system 
for the detection of porcine SOCS1 and SOCS3 we evaluated the modulation of 
these two transcripts in porcine cells upon HCMV infection. Interestingly, only 
primary cells (PAEC-KO) were found to upregulate SOCS1 mRNA transcription as 
from 24 hours p.i. on. The other cell lines tested did not reveal any particular 
modulation of SOCS1, whereas SOCS3 was not modulated in any of the cell types 
evaluated. Considering the role of endothelial cells at the interface between recipient 
blood and grafted tissue, exposed to numerous stimuli, it is reasonable to postulate 
that these cells need to be able to quickly and efficiently modulate responses to 
danger signals to ensure homeostasis. 
It also revealed the importance of the model, i.e. cell, chosen. The process of 
immortalization results in profound changes in the metabolism of the cell [192]. 
Expression of molecules involved in cell proliferation, regulation of homeostasis and 
cell cycle are changed [193,194]. Given that SOCS1 and SOCS3 are involved in a 
number of processes controlling the response to stimuli, especially via JAK/STAT, it 
is likely that changes in the expression pattern of these proteins may be related to 
the process of immortalization. Supporting this idea is the fact that in human cancer 
expression and modulation of SOCS1 and SOCS3 is altered [81,195]. We used 
HeLa cells [196] as positive control for SOCS1 and SOCS3 expression, one of the 
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oldest cell line generated from a cervix cancer and with considerable expression of 
both SOCS1 and SOCS3.  
All these findings implied that using immortalized cell lines to study the involvement 
of SOCS1 and SOCS3 in HCMV infection was prone to a number of potential 
problems. Supporting this concept results collected with the cell line MRC5 did not 
show any remarkable modulation of SOCS1 or SOCS3 upon HCMV infection. 
The upregulation of SOCS1 mRNA found in HCMV PAEC KO prompted us to 
investigate the protein level for both SOCS1 and SOCS3. Since none of the 
commercially-available antibodies were targeting porcine SOCS1 or SOCS3, we 
screened selected antibodies designed against human SOCS based on the higher 
than 90% homology between the porcine and the human SOCS1 and SOCS3. Two 
antibodies did recognize a band of the size of SOCS1, or SOCS3, respectively. 
Obtaining consistent results was very difficult, and probably due to the fact that 
cross-reactivity was limited. Encouraged by the intriguing finding of SOCS 
modulation in pEC, we shifted our investigation to the possible role of SOCS1 and 
SOCS3 during HCMV infection in human endothelial cells. 
 
 
6.2 Human setting 
 
6.2.1 Detection and induction of SOCS 
A number of viruses have been shown to exploit SOCS proteins to their advantage, 
among them EBV and the HSV-1, two members of the herpesvirus family. As initial 
investigation, a system for detection for SOCS1 and SOCS3 mRNA by the RT-PCR 
was developed. MRC5 and HMVEC were stimulated with known inducers IFNγ, 
PMA, or left untreated to evaluate the constitutive transcription rate and the 
possibility to modulate the mRNA of SOCS1 and SOCS3 expression. All cells tested 
expressed a basal level of SOCS1 and SOCS3 with modulation of the transcription 
with different stimuli. Response to the different stimuli was cell type dependent. 
Stimulation of MRC5 with PMA resulted in a strong upregulation of SOCS3 mRNA 
(about 60-fold as compared to mock control) and in a modest 10-fold induction of 
SOCS1. PMA-stimulated HMVEC showed an opposite trend where SOCS1 mRNA 
was highly (about 100-fold) expressed and SOCS3 modestly (about 15-fold) 
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modulated. A complete different pattern of expression was observed when MRC5 or 
HMVEC were stimulated with IFNγ. These results were a first sign hinting at the 
complexity of SOCSs interactions in different cells. This was confirmed by the fact 
that upon HCMV infection the rates of SOCS1 and SOCS3 expression were different 
in time and magnitude for the different cell type tested.  
Analysis of SOCS1 and SOCS3 proteins by western blot yielded an unexpected 
result. Despite the upregulation of the mRNA level for SOCS1 after HCMV infection, 
the protein level was not modulated or even decreased. This discrepancy was 
recently described by other groups who had observed this phenomenon for SOCS1. 
A possible link was found in the expression of a microRNA called mIR-155 [102]. 
mIR-155 was first identified as a putative miRNA targeting SOCS1. Based on the 
sequence and after further characterization a clear role for mIR-155 in targeting and 
inhibiting SOCS1 expression was documented [98-103]. In cells infected with VSV, 
SOCS1 mRNA expression was about 20 times higher than in non-infected cells but 
the protein level was reduced. This was correlated with the fact that infection of VSV 
upregulated mIR-155 expression which inhibits the translation of SOCS1 [102]. 
mIRNA-155 is induced by a number of different stimuli in the context of inflammation 
[104-108], and has been found to be expressed upon EBV infection [180] and KSHV, 
which carries in its genome a homologue of mIR-155 [181]. We hypothesize that the 
phenomenon we are observing in HMVEC may be due to the result of a post 
translational regulation driven by mIRNA-155. It will be of great interest to further 
investigate this point to test this hypothesis and elucidate the mechanism behind this 
apparent discrepancy.  
On the contrary, SOCS3 mRNA showed a correlation between mRNA upregulation 
observed upon stimulation and level of protein detected. Particularly intriguing is the 
fact that upon infection with HCMV, on the contrary, we did not detect any SOCS3 
mRNA modulation despite an increase in SOCS3 protein observed. SOCS3 and the 
SOCS protein in general are believed to have a fast cellular turnover. The stability of 
SOCS3 and thus its half-life can be improved and extended in several manners. 
Under stress conditions SOCS3 mRNA can be translated from different starting 
points increasing the translation level of the protein without compromising its activity. 
These alternative start codon lies just after a SOCS3 ubiquitination site, thus starting 
the translation from this codon generates a fully functional SOCS3 protein lacking an 
ubiquitination site resulting in a longer half-life [122]. Infection constitutes such a 
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stress and the alternative translation start points could be an explanation for the 
increased quantity of SOCS3 during infection in HMVEC. Stability of SOCS3 it is also 
mediated by the SOCS box. Modulation of the half-life of SOCS3 has been shown to 
be dependent on the binding of the ubiquitin machinery to the SOCS box with 
considerable extension of the half-life of the protein through stabilization of the 
complex [110,123,124]. Moreover, SOCS3 is the only SOCS protein containing a 35 
amino acid PEST [125] motive which has been described to be recognized as a site 
for protein degradation [126]. For SOCS3, this motive has been shown to be 
responsible for the cellular turnover of the protein. Removing PEST drastically 
increased the half-life of SOCS3 without compromising its activity [125]. It is possible 
that specific viral proteins can either stabilize the binding between SOCS box and 
ubiquitin machinery and/or bind to the PEST region avoiding tagging of SOCS3 for 
degradation. How HCMV infection causes this increase of SOCS3 protein remains 
unknown. 
 
6.2.2 Silencing of SOCS1 and SOCS3 
To further investigate the role of SOCS1 and SOCS3 in HCMV-infected HMVEC, 
silencing of the two genes was attempted to investigate the impact on the viral 
replication. Initially, western blot analysis of the proteins was not pointing to a 
successful silencing. Nevertheless, silenced cultures were infected with HCMV and 
viral antigen and infectious particles productions assessed. In both siSOCS1 and 
siSOCS3 conditions, a decrease in both viral antigen and progeny productions was 
observed. Similar results were seen in cultures silenced twice (two day pre infection 
and 4 days p.i.) indicating that the first silencing was sufficient. Knowing that 
silencing of primary cells can pose a challenge due to their refractory nature to 
transfection and their fragility, we needed to repeat these experiments and ensure 
that the effect observed was specific for the silenced genes and not an unspecific 
result of application of siRNA. With these experiments a first read out was provided, 
showing an impact on HCMV replication upon downregulation of SOCS1 and 
SOCS3. The quality of the western blot however did not allow determining the 
magnitude of the downregulation of the target proteins. In addition, based on these 
blots, a possible cross-reactivity between siRNA targeting SOCS3 and SOCS1 could 
not be excluded. Optimization of the western blot technique was crucial. 
Quantification of the western blot samples via nanodrop allowed loading the same 
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quantity of cells lysate for every condition and every time point. Extraction of the 
proteins on ice with a specific LB improved the signal of the target proteins allowing 
defining a threshold necessary to detect SOCS1 and SOCS3. Since SOCS are 
negative regulators of JAK/STAT pathways a control to detect possible preactivation 
of the type I IFN pathway via detection of Mx protein was introduced. Mx protein is 
one of the classical type I IFN induced proteins. The optimization revealed two 
problems: the first was that siRNA against SOCS3 also was downregulating SOCS1 
to a lesser extent, and the second was that the silencing settings used to produce to 
first results with the virus did induce Mx production. Activation of IFN type I can 
indeed produce misleading resultes with the possibility that the reduction in viral 
replication was due to the activation of type I IFN and not SOCS1 or SOCS3 
downregulation. An alternative explanation could be that the downregulation of the 
target proteins by themselves lead to an activation of the type I IFN pathway since 
mock silencing revealed inconstant amount of Mx proteins. Another important role 
was played by the age of the cells. Primary cells can duplicate only a certain number 
of times before senescence and we noticed that employing cells older than passage 
8 for silencing experiment further increased Mx induction. Solving this issue was 
mandatory as well as optimizing the specificity of the silencing. To achieve these 
purposes different strategies were evaluated. Protocols of transfection were varied, 
from the forward one we usually employed to the reverse transfection believed to be 
less invasive. Evaluation of other alternative transfection regencies was attempted. 
Unspecific induction of antiviral states as measured by Mx protein was avoided, but 
silencing was poor. To overcome the difficulties a novel approach for the 
downregulation of the target proteins was evaluated, employing a lentiviral 
transduction system. This system is based on lentiviral delivery of DNA. The system 
is based on modified lentiviral particles carrying a plasmid that encodes for shRNA 
targeting a chosen gene [197]. This system has many advantages compared to the 
conventional lipofection approach. It is based on shRNA which are more stable than 
siRNA introduced into cells by transfection, and does not need any transfection 
reagent which is much less invasive and toxic. shRNA coding DNA is integrated into 
the cellular genome and potentially allows downregulation of the target protein for an 
unlimited time. The plasmid carrying the shRNA coding DNA is linked to a GFP 
coding box allowing to determine the rate of transduced cells. The transduction 
efficiency was assessed with the wild type vector, since no previous study had 
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shown that HMVEC were transducible with these plasmids combinations. The first 
results were encouraging since a very high rate of GFP positive cells (about 90%) 
was seen. Two shRNA specific for SOCS1, one for SOCS3 and a scramble control 
were designed. After cloning of the sequences into the delivery vectors and 
packaging of the plasmids into the pseudoviral particles, HMVEC were transduced 
with the different construct. Analysis of the samples by western blot revealed that 
despite a high rate of transduced cells (about 80-90%) no downregulation of the 
target proteins was seen. It is known that certain sequences work for a given type of 
cell but fail in others.  
The breakthrough came when the initial classic method with lipofection and siRNA 
was used again with siRNA from a different company. A specific silencing for SOCS1 
and SOCS3, and with no type I IFN activation of the cells was finally achieved. The 
experiments were all repeated with the new setting. We were able to confirm that 
silencing of SOCS3 reduces HCMV replication efficiency in HMVEC and, in contrast 
with what we observed with the old silencing setting, SOCS1 downregulation did not 
impact the replication of HCMV in HMVEC. The previous observation was most 
probably due to the type I IFN activation of the cells.  
The main results are summarized and discussed in the Chapter 5.  
 
 
6.3 Conclusion 
These results for the first time reveal a role for SOCS proteins in HCMV infection. We 
have only started to elucidate the potential mechanisms behind these findings. It will 
be of interests to understand the mechanism behind HCMV-SOCS3 protein 
interference in infected cells and to investigate the role of SOCS3 in or ex vivo. 
These results will not only expand our knowledge on the biology of HCMV but may 
be a first step to develop novel therapeutical strategies targeting SOCS3.  
Dissertation 
 
 
Olmo Sonzogni • July 2012 73 
7.  References 
1. Landolfo S, Gariglio M, Gribaudo G, Lembo D (2003) The human cytomegalovirus. 
Pharmacology & Therapeutics 98: 269–297. doi:10.1016/S0163-7258(03)00034-2. 
2. Coen DM, Schaffer PA (2003) Antiherpesvirus drugs: a promising spectrum of new 
drugs and drug targets. Nat Rev Drug Discov 2: 278–288. doi:10.1038/nrd1065. 
3. Hakki M, Chou S (2011) The biology of cytomegalovirus drug resistance. Current 
Opinion in Infectious Diseases 24: 605–611. doi:10.1097/QCO.0b013e32834cfb58. 
4. Schreiber A, Härter G, Schubert A, Bunjes D, Mertens T, et al. (2009) Antiviral 
treatment of cytomegalovirus infection and resistant strains. Expert Opin 
Pharmacother 10: 191–209. doi:10.1517/14656560802678138. 
5. Härter G, Michel D (2012) Antiviral treatment of cytomegalovirus infection: an 
update. Expert Opin Pharmacother 13: 623–627. 
doi:10.1517/14656566.2012.658775. 
6. Isaacson MK, Juckem LK, Compton T (2008) Virus entry and innate immune 
activation. Curr Top Microbiol Immunol 325: 85–100. 
7. Soroceanu L, Akhavan A, Cobbs CS (2008) Platelet-derived growth factor-α receptor 
activation is required for human cytomegalovirus infection. Nature 455: 391–395. 
doi:10.1038/nature07209. 
8. Compton T, Mary HT (2002) Human cytomegalovirus glycoprotein O as a new drug 
target and subunit vaccine candidate. 
9. Marshall EE, Geballe AP (2009) Multifaceted Evasion of the Interferon Response by 
Cytomegalovirus. Journal of Interferon & Cytokine Research 29: 609–620. 
doi:10.1089/jir.2009.0064. 
10. Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, et al. (2007) 
Betaherpes viral genes and their functions. Cambridge: Cambridge University Press. 
pp. 
11. Tomtishen JP (2012) Human cytomegalovirus tegument proteins (pp65, pp71, 
pp150, pp28). Virol J 9: 22. doi:10.1186/1743-422X-9-22. 
12. Mettenleiter TC (2002) Herpesvirus assembly and egress. Journal of Virology 76: 
1537–1547. 
13. Sinzger C, Kahl M, Laib K, Klingel K, Rieger P, et al. (2000) Tropism of human 
cytomegalovirus for endothelial cells is determined by a post-entry step dependent 
on efficient translocation to the nucleus. J Gen Virol 81: 3021–3035. 
14. Streblow DN, Orloff SL, Nelson JA (2007) Acceleration of allograft failure by 
cytomegalovirus. Curr Opin Immunol 19: 577–582. doi:10.1016/j.coi.2007.07.012. 
15. Pérez-Sola MJ, Castón JJ, Solana R, Rivero A, Torre-Cisneros J (2008) Indirect 
effects of cytomegalovirus infection in solid organ transplant recipients. Enferm 
Infecc Microbiol Clin 26: 38–47. 
Dissertation 
 
 
Olmo Sonzogni • July 2012 74 
16. Snydman DR, Limaye AP, Potena L, Zamora MR (2011) Update and review: state-
of-the-art management of cytomegalovirus infection and disease following thoracic 
organ transplantation. Transplant Proc 43: S1–S17. 
doi:10.1016/j.transproceed.2011.02.069. 
17. Lemonovich TL, Watkins RR (2012) Update on cytomegalovirus infections of the 
gastrointestinal system in solid organ transplant recipients. Curr Infect Dis Rep 14: 
33–40. doi:10.1007/s11908-011-0224-6. 
18. Loebe M, Schüler S, Zais O, Warnecke H, Fleck E, et al. (1990) Role of 
cytomegalovirus infection in the development of coronary artery disease in the 
transplanted heart. J Heart Transplant 9: 707–711. 
19. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC (2003) Bronchiolitis 
obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after 
lung transplantation. Transplantation 75: 2064–2068. 
doi:10.1097/01.TP.0000069234.04901.A3. 
20. Madalosso C, de Souza NF, Ilstrup DM, Wiesner RH, Krom RA (1998) 
Cytomegalovirus and its association with hepatic artery thrombosis after liver 
transplantation. Transplantation 66: 294–297. 
21. Nett PC, Heisey DM, Fernandez LA, Sollinger HW, Pirsch JD (2004) Association of 
cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. 
Transplantation 78: 1036–1041. 
22. Varga M, Remport A, Czebe K, Péter A, Toronyi E, et al. (2008) [Cytomegalovirus 
infection after solid-organ transplantation, its risk factors, direct and indirect effects 
and prevention strategies]. Orv Hetil 149: 551–558. doi:10.1556/OH.2008.28324. 
23. Castón Osorio JJ, Zurbano Goñi F (2011) [Indirect effects of cytomegalovirus 
infection]. Enferm Infecc Microbiol Clin 29 Suppl 6: 6–10. doi:10.1016/S0213-
005X(11)70050-7. 
24. Mueller NJ, Barth RN, Yamamoto S, Kitamura H, Patience C, et al. (2002) Activation 
of cytomegalovirus in pig-to-primate organ xenotransplantation. Journal of Virology 
76: 4734–4740. 
25. Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001) Human 
cytomegalovirus productively infects porcine endothelial cells in vitro. 
Transplantation 72: 1334–1337. 
26. Millard A-L, Häberli L, Sinzger C, Ghielmetti M, Schneider MKJ, et al. (2010) 
Efficiency of porcine endothelial cell infection with human cytomegalovirus depends 
on both virus tropism and endothelial cell vascular origin. Xenotransplantation 17: 
274–287. doi:10.1111/j.1399-3089.2010.00594.x. 
27. Ghielmetti M, Millard A-L, Haeberli L, Bossart W, Seebach JD, et al. (2009) Human 
CMV Infection of Porcine Endothelial Cells Increases Adhesion Receptor Expression 
and Human Leukocyte Recruitment. Transplantation 87: 1792–1800. 
doi:10.1097/TP.0b013e3181a75a41. 
28. Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Curr Top Microbiol 
Immunol 325: 63–83. 
Dissertation 
 
 
Olmo Sonzogni • July 2012 75 
29. Fish KN, Stenglein SG, Ibanez C, Nelson JA (1995) Cytomegalovirus persistence in 
macrophages and endothelial cells. Scand J Infect Dis Suppl 99: 34–40. 
30. Jarvis MA, Nelson JA (2002) Human cytomegalovirus persistence and latency in 
endothelial cells and macrophages. Curr Opin Microbiol 5: 403–407. 
31. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK (1984) Widespread 
presence of histologically occult cytomegalovirus. Hum Pathol 15: 430–439. 
32. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, et al. (1995) Fibroblasts, 
epithelial cells, endothelial cells and smooth muscle cells are major targets of human 
cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76 ( Pt 4): 
741–750. 
33. Wiley CA, Schrier RD, Denaro FJ, Nelson JA, Lampert PW, et al. (1986) Localization 
of cytomegalovirus proteins and genome during fulminant central nervous system 
infection in an AIDS patient. J Neuropathol Exp Neurol 45: 127–139. 
34. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA (1998) Human 
cytomegalovirus persistently infects aortic endothelial cells. Journal of Virology 72: 
5661–5668. 
35. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, et al. (2006) Human 
Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte 
Extravasation and Transfer of Productive Virus To Enhance Hematogenous 
Dissemination of HCMV. Journal of Virology 80: 11539–11555. 
doi:10.1128/JVI.01016-06. 
36. Le Roy E, Mühlethaler-Mottet A, Davrinche C, Mach B, Davignon JL (1999) Escape 
of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is 
mediated by repression of gamma interferon-induced class II transactivator 
expression. Journal of Virology 73: 6582–6589. 
37. Baron M, Davignon J-L (2008) Inhibition of IFN-gamma-induced STAT1 tyrosine 
phosphorylation by human CMV is mediated by SHP2. The Journal of Immunology 
181: 5530–5536. 
38. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, et al. (1998) Human 
cytomegalovirus inhibits major histocompatibility complex class II expression by 
disruption of the Jak/Stat pathway. J Exp Med 187: 675–683. 
39. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, et al. (1994) 
Cytomegalovirus inhibits major histocompatibility class II expression on infected 
endothelial cells. Am J Pathol 144: 683–692. 
40. Knight DA, Waldman WJ, Sedmak DD (1997) Human cytomegalovirus does not 
induce human leukocyte antigen class II expression on arterial endothelial cells. 
Transplantation 63: 1366–1369. 
41. Scholz M, Hamann A, Blaheta RA, Auth MK, Encke A, et al. (1992) 
Cytomegalovirus- and interferon-related effects on human endothelial cells. 
Cytomegalovirus infection reduces upregulation of HLA class II antigen expression 
after treatment with interferon-gamma. Hum Immunol 35: 230–238. 
42. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD (1999) Human 
Dissertation 
 
 
Olmo Sonzogni • July 2012 76 
cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory 
responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 
162: 6107–6113. 
43. Zhu H, Cong JP, Shenk T (1997) Use of differential display analysis to assess the 
effect of human cytomegalovirus infection on the accumulation of cellular RNAs: 
induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 94: 13985–13990. 
44. Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T (1998) Cellular gene expression 
altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. 
Proc Natl Acad Sci USA 95: 14470–14475. 
45. Boyle KA, Pietropaolo RL, Compton T (1999) Engagement of the cellular receptor 
for glycoprotein B of human cytomegalovirus activates the interferon-responsive 
pathway. Molecular and Cellular Biology 19: 3607–3613. 
46. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, et al. (2001) Global 
modulation of cellular transcription by human cytomegalovirus is initiated by viral 
glycoprotein B. Proc Natl Acad Sci USA 98: 7140–7145. 
doi:10.1073/pnas.121177598. 
47. Browne EP, Shenk T (2003) Human cytomegalovirus UL83-coded pp65 virion 
protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci USA 
100: 11439–11444. doi:10.1073/pnas.1534570100. 
48. Abate DA, Watanabe S, Mocarski ES (2004) Major Human Cytomegalovirus 
Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation 
in the Interferon Response. Journal of Virology 78: 10995–11006. 
doi:10.1128/JVI.78.20.10995-11006.2004. 
49. DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Fruh K (2009) Human 
Cytomegalovirus Induces the Interferon Response via the DNA Sensor ZBP1. 
Journal of Virology 84: 585–598. doi:10.1128/JVI.01748-09. 
50. Le VTK, Trilling M, Wilborn M, Hengel H, Zimmermann A (2008) Human 
cytomegalovirus interferes with signal transducer and activator of transcription 
(STAT) 2 protein stability and tyrosine phosphorylation. Journal of General Virology 
89: 2416–2426. doi:10.1099/vir.0.2008/001669-0. 
51. Krauss S, Kaps J, Czech N, Paulus C, Nevels M (2009) Physical Requirements and 
Functional Consequences of Complex Formation between the Cytomegalovirus IE1 
Protein and Human STAT2. Journal of Virology 83: 12854–12870. 
doi:10.1128/JVI.01164-09. 
52. Streblow DN, Nelson JA (2003) Models of HCMV latency and reactivation. Trends 
Microbiol 11: 293–295. 
53. Mocarski ES (2004) Immune escape and exploitation strategies of 
cytomegaloviruses: impact on and imitation of the major histocompatibility system. 
Cell Microbiol 6: 707–717. doi:10.1111/j.1462-5822.2004.00425.x. 
54. Mocarski ES (2002) Immunomodulation by cytomegaloviruses: manipulative 
strategies beyond evasion. Trends Microbiol 10: 332–339. 
55. Lin A, Xu H, Yan W (2007) Modulation of HLA expression in human cytomegalovirus 
Dissertation 
 
 
Olmo Sonzogni • July 2012 77 
immune evasion. Cell Mol Immunol 4: 91–98. 
56. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, et al. (2000) Surface 
expression of HLA-E, an inhibitor of natural killer cells, enhanced by human 
cytomegalovirus gpUL40. Science 287: 1031. 
57. Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, et al. (2012) 
Human Cytomegalovirus UL40 Signal Peptide Regulates Cell Surface Expression of 
the NK Cell Ligands HLA-E and gpUL18. The Journal of Immunology 188: 2794–
2804. doi:10.4049/jimmunol.1102068. 
58. Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, et al. (2003) 
Effects of human cytomegalovirus infection on ligands for the activating NKG2D 
receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is 
counteracted by the viral UL16 protein. J Immunol 171: 902–908. 
59. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, et al. (2003) Human 
cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D 
ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197: 1427–1439. 
doi:10.1084/jem.20022059. 
60. Odeberg J, Browne H, Metkar S, Froelich CJ, Brandén L, et al. (2003) The human 
cytomegalovirus protein UL16 mediates increased resistance to natural killer cell 
cytotoxicity through resistance to cytolytic proteins. Journal of Virology 77: 4539–
4545. 
61. Valés-Gómez M, Browne H, Reyburn HT (2003) Expression of the UL16 
glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack 
by natural killer cells. BMC Immunol 4: 4. 
62. Michelson S (2004) Consequences of human cytomegalovirus mimicry. Hum 
Immunol 65: 465–475. doi:10.1016/j.humimm.2004.02.002. 
63. Jurak I, Brune W (2006) Induction of apoptosis limits cytomegalovirus cross-species 
infection. The EMBO Journal 25: 2634–2642. doi:10.1038/sj.emboj.7601133. 
64. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, et al. (1995) A novel 
cytokine-inducible gene CIS encodes an SH2-containing protein that binds to 
tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. The EMBO 
Journal 14: 2816–2826. 
65. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, et al. (1997) Structure 
and function of a new STAT-induced STAT inhibitor. Nature 387: 924–929. 
doi:10.1038/43219. 
66. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, et al. (1997) A new 
protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921–924. 
doi:10.1038/43213. 
67. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, et al. (1997) A family of 
cytokine-inducible inhibitors of signalling. Nature 387: 917–921. doi:10.1038/43206. 
68. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, et al. (1997) Cloning and 
functional analysis of new members of STAT induced STAT inhibitor (SSI) family: 
SSI-2 and SSI-3. Biochemical and Biophysical Research Communications 237: 79–
Dissertation 
 
 
Olmo Sonzogni • July 2012 78 
83. doi:10.1006/bbrc.1997.7080. 
69. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, et al. (1998) 
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc 
Natl Acad Sci USA 95: 114–119. 
70. Chen XP, Losman JA, Rothman P (2000) SOCS proteins, regulators of intracellular 
signaling. Immunity 13: 287–290. 
71. Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune 
system. Nat Rev Immunol 2: 410–416. doi:10.1038/nri818. 
72. Matsumoto A, Seki Y, Kubo M, Ohtsuka S, Suzuki A, et al. (1999) Suppression of 
STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-
containing protein 1 transgenic mice. Molecular and Cellular Biology 19: 6396–6407. 
73. Yoshimura A (2009) Regulation of cytokine signaling by the SOCS and Spred family 
proteins. Keio J Med 58: 73–83. 
74. Akhtar LN, Benveniste EN (2011) Viral Exploitation of Host SOCS Protein Functions. 
Journal of Virology 85: 1912–1921. doi:10.1128/JVI.01857-10. 
75. Croker BA, Kiu H, Nicholson SE (2008) SOCS regulation of the JAK/STAT signalling 
pathway. Seminars in Cell & Developmental Biology 19: 414–422. 
doi:10.1016/j.semcdb.2008.07.010. 
76. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HME, et al. (2002) The 
SOCS box: a tale of destruction and degradation. Trends Biochem Sci 27: 235–241. 
77. Sullivan A, Lu X (2007) ASPP: a new family of oncogenes and tumour suppressor 
genes. Br J Cancer 96: 196–200. doi:10.1038/sj.bjc.6603525. 
78. Greenhalgh CJ, Miller ME, Hilton DJ, Lund PK (2002) Suppressors of cytokine 
signaling: Relevance to gastrointestinal function and disease. Gastroenterology 123: 
2064–2081. doi:10.1053/gast.2002.37068. 
79. Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and 
immunity. Nat Immunol 4: 1169–1176. doi:10.1038/ni1012. 
80. Scutti JAB, Matsuo AL, Pereira FV, Massaoka MH, Figueiredo CR, et al. (2011) Role 
of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development. Transl Oncol 
4: 101–109. 
81. Zhang J, Li H, Yu J-P, Wang SE, Ren X-B (2012) Role of SOCS1 in tumor 
progression and therapeutic application. Int J Cancer 130: 1971–1980. 
doi:10.1002/ijc.27318. 
82. Horndasch M, Culig Z (2011) SOCS-3 antagonizes pro-apoptotic effects of TRAIL 
and resveratrol in prostate cancer cells. Prostate: n/a–n/a. doi:10.1002/pros.21353. 
83. Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and 
immune regulation. Nat Rev Immunol 7: 454–465. doi:10.1038/nri2093. 
84. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, et al. (2008) Putting out 
the fire: coordinated suppression of the innate and adaptive immune systems by 
Dissertation 
 
 
Olmo Sonzogni • July 2012 79 
SOCS1 and SOCS3 proteins. Immunol Rev 224: 265–283. doi:10.1111/j.1600-
065X.2008.00659.x. 
85. Yoshimura A (2012) SOCS, inflammation, and autoimmunity: 1–9. 
doi:10.3389/fimmu.2012.00020/abstract. 
86. Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A (2011) 
Suppressors of Cytokine Signaling (SOCS) Proteins and JAK/STAT Pathways: 
Regulation of T-Cell Inflammation by SOCS1 and SOCS3. Arteriosclerosis, 
Thrombosis, and Vascular Biology 31: 980–985. 
doi:10.1161/ATVBAHA.110.207464. 
87. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, et al. (1998) Accelerated 
apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced 
STAT inhibitor-1) deficient mice. Proc Natl Acad Sci USA 95: 15577–15582. 
88. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, et al. (1998) Liver 
degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine 
signaling-1. Proc Natl Acad Sci USA 95: 14395–14399. 
89. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, et al. (1999) SOCS1 is a 
critical inhibitor of interferon gamma signaling and prevents the potentially fatal 
neonatal actions of this cytokine. Cell 98: 597–608. 
90. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, et al. (1999) SOCS1 
deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98: 609–616. 
91. Bullen DV, Darwiche R, Metcalf D, Handman E, Alexander WS (2001) Neutralization 
of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the 
liver but not subsequent fatal inflammatory disease. Immunology 104: 92–98. 
92. Metcalf D, Mifsud S, Di Rago L, Nicola NA, Hilton DJ, et al. (2002) Polycystic 
kidneys and chronic inflammatory lesions are the delayed consequences of loss of 
the suppressor of cytokine signaling-1 (SOCS-1). Proc Natl Acad Sci USA 99: 943–
948. doi:10.1073/pnas.022628499. 
93. Tan JC, Rabkin R (2005) Suppressors of cytokine signaling in health and disease. 
Pediatr Nephrol 20: 567–575. doi:10.1007/s00467-004-1766-8. 
94. Metcalf D, Mifsud S, Di Rago L, Alexander WS (2003) The lethal effects of 
transplantation of Socs1-/- bone marrow cells into irradiated adult syngeneic 
recipients. Proc Natl Acad Sci USA 100: 8436–8441. doi:10.1073/pnas.1032925100. 
95. Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T, et al. (2000) IFN regulatory 
factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 
gene promoter by IFN-gamma. J Immunol 164: 5833–5843. 
96. Gregorieff A (2000) Regulation of SOCS-1 Expression by Translational Repression. 
Journal of Biological Chemistry 275: 21596–21604. doi:10.1074/jbc.M910087199. 
97. Schlüter G, Boinska D, Nieman-Seyde SC (2000) Evidence for translational 
repression of the SOCS-1 major open reading frame by an upstream open reading 
frame. Biochemical and Biophysical Research Communications 268: 255–261. 
doi:10.1006/bbrc.2000.2109. 
Dissertation 
 
 
Olmo Sonzogni • July 2012 80 
98. Lu C, Huang X, Zhang X, Roensch K, Cao Q, et al. (2011) miR-221 and miR-155 
regulate human dendritic cell development, apoptosis, and IL-12 production through 
targeting of p27kip1, KPC1, and SOCS-1. Blood 117: 4293–4303. 
doi:10.1182/blood-2010-12-322503. 
99. Jiang S, Zhang H-W, Lu M-H, He X-H, Li Y, et al. (2010) MicroRNA-155 functions as 
an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 
gene. Cancer Research 70: 3119–3127. doi:10.1158/0008-5472.CAN-09-4250. 
100. Cardoso AL, Guedes JR, Pereira de Almeida L, Pedroso de Lima MC (2011) miR-
155 modulates microglia-mediated immune response by down-regulating SOCS-1 
and promoting cytokine and nitric oxide production. Immunology 135: 73–88. 
doi:10.1111/j.1365-2567.2011.03514.x. 
101. di Iasio MG, Norcio A, Melloni E, Zauli G (2012) SOCS1 is significantly up-regulated 
in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples 
and shows an inverse correlation with miR-155. Invest New Drugs. 
doi:10.1007/s10637-011-9786-2. 
102. Wang P, Hou J, Lin L, Wang C, Liu X, et al. (2010) Inducible microRNA-155 
feedback promotes type I IFN signaling in antiviral innate immunity by targeting 
suppressor of cytokine signaling 1. The Journal of Immunology 185: 6226–6233. 
doi:10.4049/jimmunol.1000491. 
103. Su C, Hou Z, Zhang C, Tian Z, Zhang J (2011) Ectopic expression of microRNA-155 
enhances innate antiviral immunity against HBV infection in human hepatoma cells. 
Virol J 8: 354. doi:10.1186/1743-422X-8-354. 
104. Tili E, Michaille J-J, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of 
miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation 
and their possible roles in regulating the response to endotoxin shock. J Immunol 
179: 5082–5089. 
105. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, et al. (2009) 
MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human 
monocyte-derived dendritic cells. Proc Natl Acad Sci USA 106: 2735–2740. 
doi:10.1073/pnas.0811073106. 
106. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-
155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci 
USA 104: 1604–1609. doi:10.1073/pnas.0610731104. 
107. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, et al. (2010) 
Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment 
epithelial cells by activating JAK/STAT pathway. Biochemical and Biophysical 
Research Communications 402: 390–395. doi:10.1016/j.bbrc.2010.10.042. 
108. Forrest ARR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, et al. 
(2009) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes 
monocytic differentiation through combinatorial regulation. Leukemia 24: 460–466. 
doi:10.1038/leu.2009.246. 
109. Hanada T, Yoshida T, Kinjyo I, Minoguchi S, Yasukawa H, et al. (2001) A mutant 
form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by 
accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-
Dissertation 
 
 
Olmo Sonzogni • July 2012 81 
box. J Biol Chem 276: 40746–40754. doi:10.1074/jbc.M106139200. 
110. Kamura T, Sato S, Haque D, Liu L, Kaelin WGJ, et al. (1998) The Elongin BC 
complex interacts with the conserved SOCS-box motif present in members of the 
SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes & Development 12: 
3872–3881. Available:http://www.genesdev.org/cgi/doi/10.1101/gad.12.24.3872. 
111. Narazaki M, Fujimoto M, Matsumoto T, Morita Y, Saito H, et al. (1998) Three distinct 
domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 
6 signaling. Proc Natl Acad Sci USA 95: 13130–13134. 
112. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, et al. (1999) The 
conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B 
and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad 
Sci USA 96: 2071–2076. 
113. Chen XP, Losman JA, Cowan S, Donahue E, Fay S, et al. (2002) Pim 
serine/threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sci 
USA 99: 2175–2180. doi:10.1073/pnas.042035699. 
114. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, et al. (2001) Placental defects 
and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl 
Acad Sci USA 98: 9324–9329. doi:10.1073/pnas.161271798. 
115. Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, et al. (2003) SOCS3: an 
essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. 
The EMBO Journal 22: 372–384. doi:10.1093/emboj/cdg057. 
116. Croker BA, Krebs DL, Zhang J-G, Wormald S, Willson TA, et al. (2003) SOCS3 
negatively regulates IL-6 signaling in vivo. Nat Immunol 4: 540–545. 
doi:10.1038/ni931. 
117. Auernhammer CJ, Bousquet C, Melmed S (1999) Autoregulation of pituitary 
corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. 
Proc Natl Acad Sci USA 96: 6964–6969. 
118. Lejeune D, Demoulin JB, Renauld JC (2001) Interleukin 9 induces expression of 
three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, 
suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 
overexpression suppresses interleukin 9 signalling. Biochem J 353: 109–116. 
119. Ehlting C, Häussinger D, Bode JG (2005) Sp3 is involved in the regulation of SOCS3 
gene expression. Biochem J 387: 737–745. doi:10.1042/BJ20041101. 
120. Udvadia AJ, Templeton DJ, Horowitz JM (1995) Functional interactions between the 
retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires 
amino acids necessary for growth suppression. Proc Natl Acad Sci USA 92: 3953–
3957. 
121. Paul C, Seiliez I, Thissen JP, Le Cam A (2000) Regulation of expression of the rat 
SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids 
mRNA analysis and promoter characterization. Eur J Biochem 267: 5849–5857. 
122. Sasaki A (2002) The N-terminal Truncated Isoform of SOCS3 Translated from an 
Alternative Initiation AUG Codon under Stress Conditions Is Stable Due to the Lack 
Dissertation 
 
 
Olmo Sonzogni • July 2012 82 
of a Major Ubiquitination Site, Lys-6. Journal of Biological Chemistry 278: 2432–
2436. doi:10.1074/jbc.C200608200. 
123. Haan S (2003) Tyrosine Phosphorylation Disrupts Elongin Interaction and 
Accelerates SOCS3 Degradation. Journal of Biological Chemistry 278: 31972–
31979. doi:10.1074/jbc.M303170200. 
124. Babon JJ, Sabo JK, Zhang J-G, Nicola NA, Norton RS (2009) The SOCS Box 
Encodes a Hierarchy of Affinities for Cullin5: Implications for Ubiquitin Ligase 
Formation and Cytokine Signalling Suppression. Journal of Molecular Biology 387: 
162–174. doi:10.1016/j.jmb.2009.01.024. 
125. Babon JJ, McManus EJ, Yao S, DeSouza DP, Mielke LA, et al. (2006) The Structure 
of SOCS3 Reveals the Basis of the Extended SH2 Domain Function and Identifies 
an Unstructured Insertion That Regulates Stability. Molecular Cell 22: 205–216. 
doi:10.1016/j.molcel.2006.03.024. 
126. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. 
Trends Biochem Sci 21: 267–271. 
127. Jegalian AG, Wu H (2002) Differential roles of SOCS family members in EpoR signal 
transduction. J Interferon Cytokine Res 22: 853–860. 
doi:10.1089/107999002760274863. 
128. Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, et al. (2002) Growth 
enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is 
dependent on signal transducer and activator of transcription 5b (STAT5b). Mol 
Endocrinol 16: 1394–1406. 
129. Favre H, Benhamou A, Finidori J, Kelly PA, Edery M (1999) Dual effects of 
suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. 
FEBS Lett 453: 63–66. 
130. Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, Uren R, et al. (2002) Biological 
evidence that SOCS-2 can act either as an enhancer or suppressor of growth 
hormone signaling. J Biol Chem 277: 40181–40184. doi:10.1074/jbc.C200450200. 
131. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, et al. (2000) Gigantism in 
mice lacking suppressor of cytokine signalling-2. Nature 405: 1069–1073. 
doi:10.1038/35016611. 
132. Kario E (2005) Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal 
Growth Factor Receptor Signaling. Journal of Biological Chemistry 280: 7038–7048. 
doi:10.1074/jbc.M408575200. 
133. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, et al. (1999) Mutational 
analyses of the SOCS proteins suggest a dual domain requirement but distinct 
mechanisms for inhibition of LIF and IL-6 signal transduction. The EMBO Journal 18: 
375–385. doi:10.1093/emboj/18.2.375. 
134. Krebs DL, Uren RT, Metcalf D, Rakar S, Zhang J-G, et al. (2002) SOCS-6 binds to 
insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth 
retardation. Molecular and Cellular Biology 22: 4567–4578. 
135. Li L, Grønning LM, Anderson PO, Li S, Edvardsen K, et al. (2004) Insulin induces 
Dissertation 
 
 
Olmo Sonzogni • July 2012 83 
SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-
kinase, resulting in improvement in glucose metabolism. J Biol Chem 279: 34107–
34114. doi:10.1074/jbc.M312672200. 
136. Moore EC, Barber J, Tripp RA (2008) Respiratory syncytial virus (RSV) attachment 
and nonstructural proteins modify the type I interferon response associated with 
suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 
(ISG15). Virol J 5: 116. doi:10.1186/1743-422X-5-116. 
137. Miller RC, Schlaepfer E, Baenziger S, Crameri R, Zeller S, et al. (2011) HIV 
interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J 
Immunol 41: 1058–1069. doi:10.1002/eji.201041198. 
138. Subramanya S, Armant M, Salkowitz JR, Nyakeriga AM, Haridas V, et al. (2010) 
Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-
targeted delivery of SOCS-1 siRNA. Mol Ther 18: 2028–2037. 
doi:10.1038/mt.2010.148. 
139. Michaud F, Coulombe F, Gaudreault E, Paquet-Bouchard C, Rola-Pleszczynski M, 
et al. (2010) Epstein-Barr Virus Interferes with the Amplification of IFNα Secretion by 
Activating Suppressor of Cytokine Signaling 3 in Primary Human Monocytes. PLoS 
ONE 5: e11908. doi:10.1371/journal.pone.0011908.t001. 
140. Frey KG, Ahmed CMI, Dabelic R, Jager LD, Noon-Song EN, et al. (2009) HSV-1-
Induced SOCS-1 Expression in Keratinocytes: Use of a SOCS-1 Antagonist to Block 
a Novel Mechanism of Viral Immune Evasion. The Journal of Immunology 183: 
1253–1262. doi:10.4049/jimmunol.0900570. 
141. Yokota S-I, Yokosawa N, Okabayashi T, Suzutani T, Miura S, et al. (2004) Induction 
of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to 
inhibition of the interferon signaling pathway. Journal of Virology 78: 6282–6286. 
doi:10.1128/JVI.78.12.6282-6286.2004. 
142. YOKOTA S, YOKOSAWA N, OKABAYASHI T, SUZUTANI T, FUJII N (2005) 
Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 
confers efficient viral replication. Virology 338: 173–181. 
doi:10.1016/j.virol.2005.04.028. 
143. Mahller YY, Sakthivel B, Baird WH, Aronow BJ, Hsu Y-H, et al. (2008) Molecular 
analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple 
upregulated cellular genes and a role for SOCS1 in virus replication. Cancer Gene 
Ther 15: 733–741. doi:10.1038/cgt.2008.40. 
144. Koeberlein B, Hausen zur A, Bektas N, Zentgraf H, Chin R, et al. (2010) Hepatitis B 
virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby 
contributing to severity of inflammation in the liver. Virus Res 148: 51–59. 
doi:10.1016/j.virusres.2009.12.003. 
145. Bock C-T, Toan NL, Koeberlein B, Song LH, Chin R, et al. (2008) Subcellular 
mislocalization of mutant hepatitis B X proteins contributes to modulation of 
STAT/SOCS signaling in hepatocellular carcinoma. Intervirology 51: 432–443. 
doi:10.1159/000209672. 
146. Ye L, Wang X, Metzger DS, Riedel E, Montaner LJ, et al. (2010) Upregulation of 
SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56+ 
Dissertation 
 
 
Olmo Sonzogni • July 2012 84 
T Cells in HCV-Infected Heroin Users. PLoS ONE 5: e9602. 
doi:10.1371/journal.pone.0009602.t002. 
147. MIYOSHI H, FUJIE H, SHINTANI Y, TSUTSUMI T, SHINZAWA S, et al. (2005) 
Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine 
signaling gene expression. Journal of Hepatology 43: 757–763. 
doi:10.1016/j.jhep.2005.03.028. 
148. Pazienza V, Vinciguerra M, Andriulli A, Mangia A (2010) Hepatitis C virus core 
protein genotype 3a increases SOCS-7 expression through PPAR-  in Huh-7 cells. 
Journal of General Virology 91: 1678–1686. doi:10.1099/vir.0.020644-0. 
149. Pauli E-K, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A virus 
inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 
expression. PLoS Pathog 4: e1000196. doi:10.1371/journal.ppat.1000196. 
150. Hashimoto K, Ishibashi K, Ishioka K, Zhao D, Sato M, et al. (2009) RSV replication is 
attenuated by counteracting expression of the suppressor of cytokine signaling 
(SOCS) molecules. Virology 391: 162–170. doi:10.1016/j.virol.2009.06.026. 
151. Yadav A, Fitzgerald P, Sajadi MM, Gilliam B, Lafferty MK, et al. (2009) Increased 
expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for 
dysregulated T helper-1 responses in HIV-1 disease. Virology 385: 126–133. 
doi:10.1016/j.virol.2008.11.039. 
152. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of 
type I and type II interferons in antiviral defense. Science 264: 1918–1921. 
153. Lo AKF, Lo KW, Tsao SW, Wong HL, Hui JWY, et al. (2006) Epstein-Barr Virus 
Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial Cells. 
NEO 8: 173–180. doi:10.1593/neo.05625. 
154. Nachtwey J, Spencer JV (2008) HCMV IL-10 Suppresses Cytokine Expression in 
Monocytes Through Inhibition of Nuclear Factor- κB. Viral Immunology 21: 477–482. 
doi:10.1089/vim.2008.0048. 
155. Carlier J, Martin H, Mariame B, Rauwel B, Mengelle C, et al. (2011) Paracrine 
inhibition of GM-CSF signaling by human cytomegalovirus in monocytes 
differentiating to dendritic cells. Blood 118: 6783–6792. doi:10.1182/blood-2011-02-
337956. 
156. Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, et al. (2007) Molecular 
mechanism of lipopolysaccharide-induced SOCS-3 gene expression in 
macrophages and microglia. J Immunol 179: 5966–5976. 
157. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, et al. (2006) IL-10 inhibits 
lipopolysaccharide-induced CD40 gene expression through induction of suppressor 
of cytokine signaling-3. J Immunol 177: 7761–7771. 
158. Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, et al. (2003) Activation 
of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially 
modulated by suppressor of cytokine signaling 3. J Immunol 170: 3263–3272. 
159. Delgado-Ortega M, Melo S, Meurens F (2011) Expression of SOCS1-7 and CIS 
mRNA in porcine tissues. Veterinary Immunology and Immunopathology: 1–6. 
Dissertation 
 
 
Olmo Sonzogni • July 2012 85 
doi:10.1016/j.vetimm.2011.08.002. 
160. Royaee AR, Husmann RJ, Dawson HD, Calzada-Nova G, Schnitzlein WM, et al. 
(2004) Deciphering the involvement of innate immune factors in the development of 
the host response to PRRSV vaccination. Veterinary Immunology and 
Immunopathology 102: 199–216. doi:10.1016/j.vetimm.2004.09.018. 
161. Wysocki M, Chen H, Steibel JP, Kuhar D, Petry D, et al. (2011) Identifying putative 
candidate genes and pathways involved in immune responses to porcine 
reproductive and respiratory syndrome virus (PRRSV) infection. Animal Genetics 43: 
328–332. doi:10.1111/j.1365-2052.2011.02251.x. 
162. Uthe JJ, Royaee A, Lunney JK, Stabel TJ, Zhao S-H, et al. (2007) Porcine 
differential gene expression in response to Salmonella enterica serovars 
Choleraesuis and Typhimurium. Molecular Immunology 44: 2900–2914. 
doi:10.1016/j.molimm.2007.01.016. 
163. Du B-W, Yang G-S, Sun C (2007) [Cloning and sequence analysis of SOCS-2 gene 
in pig]. Sheng Wu Gong Cheng Xue Bao 23: 1091–1096. 
164. Bruel TE, Guibon R, Melo S, n NG, Salmon H, et al. (2010) Epithelial induction of 
porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to 
Entamoeba histolytica. 34: 562–571. doi:10.1016/j.dci.2009.12.017. 
165. Weber TE, Kerr BJ (2006) Butyrate differentially regulates cytokines and proliferation 
in porcine peripheral blood mononuclear cells. Veterinary Immunology and 
Immunopathology 113: 139–147. doi:10.1016/j.vetimm.2006.04.006. 
166. Orth JHC, Aktories K, Kubatzky KF (2007) Modulation of host cell gene expression 
through activation of STAT transcription factors by Pasteurella multocida toxin. J Biol 
Chem 282: 3050–3057. doi:10.1074/jbc.M609018200. 
167. WU J, WANG B, ZHANG H, YU T, YANG G (2007) Different Transcription Profiles of 
SOCS-3, ob and IGF-I Genes and their Possible Correlations in Obese and Lean 
Pigs. Acta Biochim Biophys Sinica 39: 305–310. doi:10.1111/j.1745-
7270.2007.00274.x. 
168. ZHANG H, WU J, WANG B, Lü Z, YANG G (2008) [Regulation of SOCS-3, OB, 
GLUT4 and PPARgamma gene expression by insulin and dexamethasone in 
porcine primary adipocyte]. Sheng Wu Gong Cheng Xue Bao 24: 1354–1360. 
169. Ghielmetti M (2009) Human Leukocyte Recruitment to the Porcine Endothelium: 
Implications for Xenotransplantation. Thesis Nr. 18383, Swiss Federal Institute of 
Technology Zurich, Switzerland  
170. Seebach JD, Schneider MK, Comrack CA, LeGuern A, Kolb SA, et al. (2001) 
Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 8: 48–
61. 
171. Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, et al. (2000) 
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. FEBS 
Lett 478: 100–104. 
172. Naldini L, Blömer U, Gage FH, Trono D, Verma IM (1996) Efficient transfer, 
integration, and sustained long-term expression of the transgene in adult rat brains 
Dissertation 
 
 
Olmo Sonzogni • July 2012 86 
injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382–11388. 
173. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation 
lentivirus vector with a conditional packaging system. Journal of Virology 72: 8463–
8471. 
174. Song MM, Shuai K (1998) The suppressor of cytokine signaling (SOCS) 1 and 
SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and 
antiproliferative activities. J Biol Chem 273: 35056–35062. 
175. Koeberlein B, Hausen AZ, Bektas N, Zentgraf H, Chin R, et al. (2010) Hepatitis B 
virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby 
contributing to severity of inflammation in the liver. Virus Res 148: 51–59. 
doi:10.1016/j.virusres.2009.12.003. 
176. Benz C, Reusch U, Muranyi W, Brune W, Atalay R, et al. (2001) Efficient 
downregulation of major histocompatibility complex class I molecules in human 
epithelial cells infected with cytomegalovirus. J Gen Virol 82: 2061–2070. 
177. del Val M, Hengel H, Häcker H, Hartlaub U, Ruppert T, et al. (1992) 
Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-
loaded major histocompatibility complex class I molecules into the medial-Golgi 
compartment. J Exp Med 176: 729–738. 
178. Beersma MF, Bijlmakers MJ, Ploegh HL (1993) Human cytomegalovirus down-
regulates HLA class I expression by reducing the stability of class I H chains. J 
Immunol 151: 4455–4464. 
179. Cebulla CM, Miller DM, Zhang Y, Rahill BM, Zimmerman P, et al. (2002) Human 
cytomegalovirus disrupts constitutive MHC class II expression. J Immunol 169: 167–
176. 
180. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, et al. (2008) Epstein-Barr virus-
induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus 
persistence. Journal of Virology 82: 10436–10443. doi:10.1128/JVI.00752-08. 
181. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, et al. (2007) Kaposi's 
Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155. Journal of 
Virology 81: 12836–12845. doi:10.1128/JVI.01804-07. 
182. Paulus C, Krauss S, Nevels M (2006) A human cytomegalovirus antagonist of type I 
IFN-dependent signal transducer and activator of transcription signaling. Proc Natl 
Acad Sci USA 103: 3840–3845. doi:10.1073/pnas.0600007103. 
183. Sinzger C, Schmidt K, Knapp J, Kahl M, Beck R, et al. (1999) Modification of human 
cytomegalovirus tropism through propagation in vitro is associated with changes in 
the viral genome. J Gen Virol 80 ( Pt 11): 2867–2877. 
184. Jacobs JP, Jones CM, Baille JP (1970) Characteristics of a human diploid cell 
designated MRC-5. Nature 227: 168–170. 
185. Mahy BWJ (1996) Virology methods manual. Academic Pr. pp. 
186. Bossart W, Nuss DL, Paoletti E (1978) Effect of UV irradiation on the expression of 
vaccinia virus gene products synthesized in a cell-free system coupling transcription 
Dissertation 
 
 
Olmo Sonzogni • July 2012 87 
and translation. Journal of Virology 26: 673–680. 
187. Watson S, Mercier S, Bye C, Wilkinson J, Cunningham A, et al. (2007) 
Determination of Suitable Housekeeping Genes for Normalisation of Quantitative 
Real Time PCR Analysis of Cells Infected with Human Immunodeficiency Virus and 
Herpes Viruses. Virol J 4: 130. doi:10.1186/1743-422X-4-130. 
188. Ekser B, Ezzelarab M, Hara H, van der Windt DJ, Wijkstrom M, et al. (2012) Clinical 
xenotransplantation: the next medical revolution? Lancet 379: 672–683. 
doi:10.1016/S0140-6736(11)61091-X. 
189. Garkavenko O, Durbin K, Tan P, Elliott R (2011) Islets transplantation: New Zealand 
experience. Xenotransplantation 18: 60–60. doi:10.1111/j.1399-
3089.2010.00607_3.x. 
190. Yamada K, Scalea J (2012) Current progress in xenogeneic tolerance. Curr Opin 
Organ Transplant 17: 168–173. doi:10.1097/MOT.0b013e32835090f6. 
191. Fishman JA, Scobie L, Takeuchi Y (2012) Xenotransplantation-associated infectious 
risk: a WHO consultation. Xenotransplantation 19: 72–81. doi:10.1111/j.1399-
3089.2012.00693.x. 
192. Oh H-Y, Jin X, Kim J-G, Oh M-J, Pian X, et al. (2007) Characteristics of primary and 
immortalized fibroblast cells derived from the miniature and domestic pigs. BMC Cell 
Biol 8: 20. doi:10.1186/1471-2121-8-20. 
193. Cheng J, Zhang D, Zhou C, Marasco WA (2004) Down-regulation of SHP1 and up-
regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell 
lines and freshly transformed human peripheral blood CD4+ T-Cells. Leukemia 
Research 28: 71–82. doi:10.1016/S0145-2126(03)00158-9. 
194. Freshney RI (2011) Culture of Animal Cells. Hoboken, NJ, USA: John Wiley & Sons, 
Inc. pp. doi:10.1002/9780470649367.ch17. 
195. Zhang S, Wang W, Wang E, Qiu X (2012) SOCS3 expression is inversely correlated 
with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation 
and invasion of A549 cells. Pathology. doi:10.1097/PAT.0b013e328354ffdf. 
196. SCHERER WFW, SYVERTON JTJ, GEY GOG (1953) Studies on the propagation in 
vitro of poliomyelitis viruses.  IV.  Viral multiplication in a stable strain of human 
malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the 
cervix. J Exp Med 97: 695–710. 
197. Sakoda T, Kasahara N, Kedes L, Ohyanagi M (2007) Lentiviral Vector‐Mediated 
Gene Transfer to Endotherial Cells Compared with Adenoviral and Retroviral 
Vectors. Preparative Biochemistry and Biotechnology 37: 1–11. 
doi:10.1080/10826060601039345. 
 
Dissertation 
 
 
Olmo Sonzogni • July 2012 88 
8.  List of abbreviations 
2A2   bone marrow derived endothelial cells 
BSA  bovine serum albumin 
CIS  cytokine-inducible SH2 
CMV-MoDCs  CMV-infected MoDCs 
CNTF  ciliary neuronotrophic factor 
DNAM-1 DNAX accessory molecule-1 
E  early 
EBV  Epstein Barr virus 
EC  endothelial cells  
EGF  epidermal growth factor 
EPO  erythropoietin 
Fw.  Forward 
DT  double transfected 
g  glycoprotein 
G-CSF  granulocyte colony stimulation factor 
GFP  green fluorescence protein 
GH  growth hormone 
GM-CSF  granulocyte-macrophage colony-stimulating factor  
HAEC  primary aortic endothelial cells 
HCMV  human cytomegalovirus 
HLA  human leukocyte antigen 
HMVEC human primary lung-derived endothelial cells 
HSV  herpes simplex virus 
HUVEC  human umbilical vein endothelial cells 
IFN  interferon 
IGF-1  insulin-like growth factor-1 
IRF9  IFN regulatory factor-9 
IE  immediate early 
IL  interleukin 
JAK  janus kinase 
KSHV  Kaposi's sarcoma-associated herpes virus 
KIR  kinase inhibitor region 
L  late 
LB  lysis buffer 
LIF  leukemia inhibitory factor 
LPS   lipopolysaccharide 
M-CSF  macrophage-colony stimulating factor 
MHC  major histocompatibility complex 
mIR-155 microRNA-155 
MoDCs  monocytes-derived dendritic cells  
MOI  multiplicity of infection 
MRC5  human lung derived fibroblast 
Mx  myxovirus resistance 
NK  natural killer 
NKG2D  natural killer group 2 member D 
N.T.  non-transfected 
PEDSV.15  endothelial cells from aortic origin 
PAEC-KO  porcine aortic EC knock-out for α1,3 galactosyltransferase  
PAMPs  pathogen-associated molecular patterns 
pEC  porcine endothelial cells 
PEST  Proline, Glutamate, Aspartate, Serine and Threonine 
PMA  phorbol 12-myristate 13-acetate 
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p.i.  post infection 
p.s.  post stimulation 
RT-PCR  real time polymerase chain reaction  
Rv.  Reverse 
SD  standard deviation 
SDS-Gel sodium dodecyl sulfate polyacrylamide gel electrophoresis 
shRNA  short hairpin RNA 
siRNA  short interfering RNA 
siCNTR  silenced control  
siSOCS silenced SOCS 
SOCS  suppressor of cytokine signaling 
SOCS-/-  SOCS deficient mice 
ST  single transfected 
STAT  signal transducer and activator of transcription 
TLR  toll like receptor 
TNFα  tumor necrosis factor α 
TPO  thrombopoietin 
TSH  thyroid stimulating hormone 
TSLP  thymic stromal lymphopoietin 
US  unique short protein 
VSV  vesicular stomatitis virus 
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